Aseptic cartridge and dispenser arrangement

ABSTRACT

A cartridge for use with a beneficial agent delivery device having a tillable reservoir. The cartridge includes a reconstitution, unit dose package having first and second compartments and a fitment. The first compartment contains at least a first constituent of the beneficial agent. The second compartment contains at least a second constituent of the beneficial agent. The fitment is disposed on the package for interfacing the package to the tillable reservoir.

TECHNICAL FIELD

The present disclosure preferably, but without limitation, generallypertains to disposable cartridges for use with drug delivery devices,and more specifically pertains to aseptic mixing cartridges for drugdelivery devices.

BACKGROUND

Medications, and in particular injectable medications, need to be storedsterile in aseptic commercial packages until the time of use. Somemedications are stored in pre-filled single dose dispensing devices suchas pre-filled syringes, for example the pre-filled syringes from Vetter(Ravensburg, Germany). Yet most of injectable medication are stored inaseptic packages and are transferred to a dispensing device (i.e. drugdelivery device) shortly before use. The term dispensing device includewithout limitation hypodermic syringes, micro-needle syringes,micro-pumps, auto-injectors, jet injectors, topical dispensers,intradermal delivery devices, patch pumps, auricular dispensers, oraldispensers, eye droppers, auto-injectors, infusers, or any other type ofdrug delivery device.

Several aseptic packages for storing injectable medications arecommercially available. Perhaps the most common aseptic package forinjectable products is glass vials. Some medications are stored inseparate components that are mixed just prior to use. Often this is doneto improve the medication's stability or to extend the medication'sshelf life. In one example the medication is a vaccine that is kept dryin one vial to extend the vaccine thermo stability; and a companion vialstores a dilutant that is dispensed to the vaccine vial via a syringeand needle prior to injection. In another example the medication is avaccine where one vial stores the formulated antigen and the second vialstores an adjuvant.

However, there are several drawbacks with this prior art: (a) thesepackages are often costly and economically impractical to manyinjectable drugs such as vaccines; (b) where mixing of the medicationcomponents is required the process is complex and error prone; and (c)the transfer of the medication or its components from one container toanother or to the dispensing device is done in a non-sterile field andis prone to contamination risks.

U.S. Pat. No. 7,879,018 discloses one of several commercial and patentedkits for mixing an injectable dose. Here again the limitation of thedisclosure is the dependency on vials and the cost and complexitiesassociated with this type of glass primary containers.

Several commercial products and patents disclose a flexible package madefrom film or foils in which a product can be stored in an aseptic manneruntil the time of use. Some of these products and patents furtherdisclose a dispensing port communicating with the product in thedispensing package. In some cases a rupturable barrier is presentedbetween the port and the product to enhance the integrity of the packageuntil the time of use. In some cases these flexible packages comprise atleast two product compartments that are mergeable prior to use to allowthe substances from the different compartments to mix and form thedispensable product. In some cases these packages are made from a filmor a foil (together webs) where a first web wall is sealed to a secondweb wall to define the boundaries of a product compartment. Thesepackages are sometimes referred to as pouches or sachet. Onedisadvantage of pouch packages is that it is relatively challenging toefficiently express the entire content of the package. This is due tothe dimensional ratio of these packages where the length and width ofthe seal (the compartment's footprint) are typically significantlylarger than the perpendicular inflation to the footprint plane. Thisratio is an inherent limitation of the way pouch/sachet packages areformed. Pouches and sachets are formed from one or more flat film orfoil (together “web”) that is sealed along its edges to form one or morereceptacle. The pouch is filled during or post formation of thereceptacle and then sealed to keep the product aseptically packaged.

When operated directly with the palm, one limitation of these relativelyshallow packages is that, when dispensing, the thumb of the operatorvery quickly bring two opposite walls of the package in contact at whichpoint the dispensing is halted. Sophisticated peristaltic action orfolding of the package would typically be necessary to expressadditional product from the package, not practical for certainapplications such as injection. In some arrangements, the flexiblepackage is depressed with a compression panel to cause the content toexpel. In these arrangements it is beneficial to operate the compressionpanel to depress a smaller contact surface of the product compartment,and hence allow developing more pressure. It is therefore advantageousto create a flexible dispensing package where the footprint of thecontent compartment is relatively small and the ratio between the sealedarea and the dimension of the package perpendicular to that surface issmaller.

In some applications, the deliverable medication requires a thorough mixof at least two substances prior to injection. In one example, a simplemethod is required to prepare a highly viscous water in oil (W/O) atpoint of use. At present, an emulsion is prepared by hand by mixingseparate oil and water components back and forth via three-way stopcockor a narrow tube connecting two syringes. The method is somewhat timeconsuming and often inconsistent. Connectors that have a porous membraneinside the syringes have been developed to provide more effectiveemulsion but at the expense of needing stronger pushing forceparticularly when pore diameter is decreased in order to shortenpreparation time. In addition the increased number of assembly anddismantle steps enhance the risks of operation errors and contaminationof the deliverable dose.

SUMMARY

At least some aspects of the present disclosure overcome thedisadvantages and limitations of the prior art by providing, forexample, a low cost, simple and easy to use cartridge. The cartridge, incertain configurations, allows for aseptic mixing and filling ofdispensers or other delivery device, and in particular, drug deliveryinjectors. The terms dispenser, dispensing device, delivery device anddelivering device are used interchangeably herein.

In some arrangements of the present disclosure, the package is made fromat least one web material wherein a first wall and a second wall of theweb material are joined together along a boundary line of a compartment.In some arrangements, the web material is pre-formed such that arelatively large volume of the compartment is achieved with a relativelysmaller sealing footprint. This pre-formed package may reduce theoverall dimensions of the package and improve storage and transportationefficiencies.

According to one arrangement of the present disclosure, a cartridgehaving a thin and flexible wall package comprises at least a firstconstituent compartment and a fitment for connecting the cartridge to afilling port of a dispenser or delivery device. The fitment is attachedto the package in a fluid-tight fashion. The fitment may be attached tothe filling port of the dispenser by one of the means, but is notlimited to a Luer connector, a Luer lock connector, a press-fitconnector, a snap-on connector, a snap, a thermal weld, a spike andstopper arrangement, or a screw on cap.

In some arrangements, at least one cavity is pre-formed in at least oneof the web walls of the package, which provides a portion of at leastone product compartment of the package. This configuration allows asmaller ratio of the sealed area (footprint) of the compartment and thedimension of the compartment perpendicular to the sealed area (theswelling of the compartment), for storing the same volume of product.This configuration also permits a smaller footprint of the compartmentthan what would be required with a sachet/pouch package with a similarproduct volume. The term pre-forming, as will be used in this text,refers to giving a material, and particularly a wall of a package, athree dimensional shape. Pre-forming may include creating of a cavity, adome, a vertical or a substantially vertical wall relative to agenerally horizontal and flat original state. Pre-forming of the web maybe performed by one of the means known in the art, appropriate to theproperties of the particular web material including, for example,thermoforming, cold forming, forming with preheat, plug-assist, pressureforming, vacuum forming, and a combination of the above.

In some arrangements, the package is constructed from a thin wall in oneof the forms known in the art including, for example, a blister pack, apouch, a sachet, a blow-molded container, injection molded container, anextruded container, and a combination thereof. In some arrangements, thepackage may have more than one compartment for storing a number ofsubstances that need to be mixed prior to delivery to a subject to formthe dispensable product. In some arrangements, the package may have morethan one compartment for storing a number of substances that need not tobe mixed prior to dispensing from the package. The compartments may beseparated by a weak seal that can be broken by compressing at least oneof the compartments to cause the content to exceed a threshold pressurethat will cause the weak seal to separate (e.g., rupture or peel) andallow the substances to mix. The package further comprises an interfaceto the dispenser or delivery device.

In some arrangements, the product is transferred from the cartridge tothe dispensing device. In some arrangements, the cartridge is replacedin the dispensing device. In some embodiments, the cartridge isconnected to the dispenser in an aseptic fashion at the manufacturingstage; thus, no integration steps of the cartridge and dispenser arerequired by the user. This arrangement reduces the possibility for usererror or contamination of the device or the deliverable product as itavoids exposure to a non-sterile field prior or during the dispenserfilling/loading process. In another arrangement, the cartridge is storedseparately from the dispensing device (i.e. syringe, injector, etc.)until the time of use. This arrangement may be advantageous where thedrug needs to be stored and transported in a controlled environment,such as in controlled temperature refrigeration, and where packagingdensity is important for efficient utilization of the refrigerationspace. This arrangement may also be advantageous to increase logisticand user flexibility by allowing integration of the cartridge with adispenser from different sources.

In some arrangements, the dispensing device may be an injector. The terminjector may refer to various dispensing products including syringes,micro-infusion pumps and reservoirs of such, pen injectors, reservoirassemblies, syringes, needle-free injectors, drug delivery devices ingeneral, patch devices, etc. More generally, the cartridge of thepresent disclosure is applicable for dispensing devices including, forexample, ocular oral or auricular droppers, spray or foam dispensers,topical applicators, and inhaler devices.

In another arrangement, a static mixer is disposed at the interfacebetween the cartridge and the drug delivery device to enhance the mixingand homogeneity of the deliverable product. An example of a static mixeris taught in U.S. Pat. No. 4,538,920, which is incorporated herein inits entirety by this reference. In some arrangements, the static mixeris constructed as a pattern of passageways formed between the flexiblewalls of the package by pre-forming and weld sealing in designated areasof the package walls. The static mixer may be merely a narrow nozzle, ora porous component accommodated in the flow passageway between thecartridge and the delivery device. In one arrangement, the static mixeris disposed in the cartridge port. In one arrangement, the cartridgecomprises more than one compartment holding different substances, whichare merged prior to transferring the content to the delivery device, andthe static mixer enhances the mixing of the substances as they aretransferred to the delivery device.

In some arrangements, the mixture may be transferred back and forthbetween the cartridge and delivery device to further mix the substances.In some arrangements, at least one substance is stored in the cartridgeand at least one substance is stored in the delivery device and thesubstances are transferred back and forth between the two to mix thesubstances. In one arrangement, the cartridge comprises at least a firstand a second compartment and at least one static mixer is disposedbetween the first compartment and the second compartment. Mixing may beenhanced by transferring the substances/mixture from one compartment tothe other compartment. At least one compression panel or an arrangementof compression panels may be operated with the cartridge to facilitatethe transfer of substances across the static mixer.

The present disclosure also relates to arrangements and methods forfacilitating efficient cartridge manufacturing and filling. In onearrangement, a compartment of the package is filled with fluid. Thecompartment is pre-formed and sealed leaving a designated passagewayopen that leads to a port through which the fluid is introduced and theair is evacuated. A separate passageway for gas evacuation may beincorporated. The passageway may be constructed such that the fluidentering the port glides along the wall of the package, hence avoidingjetting, and minimizing foaming or air bubble formation, thus allowingincreased filling rate.

In another arrangement, a liquid substance is frozen prior to fillingand is introduced into the package in a solid form. The temperaturearound the package and the heat transfer to the package during thefilling process is controlled such that the frozen liquid remainssubstantially solid until the compartment is sealed. The frozen liquidsubstance dose may be inspected in that form prior or during filling.This filling arrangement and method enhances the filling speed and thesubstance inspection capability. In one arrangement, a dry powdersubstance has to be filled into the cartridge compartment. To facilitateproper filling of the powder, the powder is slightly compressed to forma loosely aggregated tablet and is filled in that form into thecompartment of the package. The tablet may be inspected prior or duringfilling to the cartridge. In one arrangement, after the tablet has beensealed in the compartment, the compartment is externally manipulated tode-agglomerate the tablet, thus improving the substance solubility atthe time of mixing with a dilutant. The external manipulation may be atleast one of, but not limited to, compression of the compartment,vibration including, for example, ultrasonic vibration, radio frequencyvibration, acoustic vibration, applying mechanical impact to thecompartment, and exposure to high or low temperatures.

The present disclosure further relates to arrangements that enhance thebarrier properties of the package by including a high barrier peelableopaque wall layer. The peelable high barrier layer may include analuminum laminate or foil that provides the benefits of light blocking,and substantially complete moisture and oxygen barrier. In order to havea visual inspection of the content of the cartridge prior to use, thehigh barrier layer is peeled from at least a portion of the package,exposing a substantially see-through wall. In one arrangement, thepeelable layer is an integral layer or layers of the multi-layer webmaterial from which the package is made. In another arrangement thepeelable layer is applied to the see-through wall during the cartridgemanufacturing process. In one arrangement the peelable layer is flat. Inanother arrangement the peelable layer is pre-formed to accommodate theform of the substance or compartment that it is protecting. In onearrangement, the peelable layer comprises a registered adhesive coatingselectively applied to the sealing circumference of the peelable layer.In one arrangement, the cartridge is in the fashion of a flexibleclear-wall tube, and the peelable layer is arranged to wrap around thetube.

Another aspect of the present disclosure relates to a cartridge for usewith a beneficial agent delivery device having a fillable reservoir. Thecartridge includes a unit dose mixing package having first and secondcompartments, and a fitment. The first compartment contains at least afirst constituent of the beneficial agent. The second compartmentcontains at least a second constituent of the beneficial agent. Thefitment is disposed on the package for interfacing the package to thefillable reservoir.

The cartridge may be adapted to communicate with a delivery portion ofthe delivery device that comprises one of a needle, a catheter, acanula, a connector and a nozzle. The delivery portion may include aneedle, and the fitment seals around the needle to minimize fluidicdead-space. The cartridge may include a rupturable barrier between thefirst compartment and the fitment. The first compartment may besegregated from the second compartment by a rupturable barrier. At leasta portion of the package may include a flexible wall. At least a portionof the flexible wall may include a foil. At least a portion of theflexible wall may be pre-formed to define at least a portion of thefirst and second compartments. At least a portion of the flexible wallmay include a peelable foil layer. At least a portion of the peelablefoil layer may be pre-formed.

The cartridge may include a fluid passageway between the first andsecond compartments. The cartridge may include a static mixer disposedin the fluid passageway. The cartridge may include a fluid passagewaybetween the package and the delivery device, and a static mixer disposedin the fluid passageway. The package may include a flexible wall thatforms at least a portion of a removable aseptic closure to the fitment.

The cartridge may include a filling compartment, a fluid passageway,wherein the filling compartment is in fluid communication with the firstcompartment via the fluid passageway. The cartridge may include firstand second package walls, and the filling compartment may be locatedbetween the first and second package walls of the package. The fluidpassageway may be sealable. The fluid passageway may be sealable tohermetically seal the first compartment after filling. The fluidpassageway may be sealable to prevent backflow to the fillingcompartment during or after filling. A thermal seal may be includedbetween the first and second package walls to seal the fluid passageway.The cartridge may include an insert disposed in at least one of thefilling compartment and the fluid passageway. The insert may provide atleast a portion of a flow control device such as a valve, a check-valve,a flow restrictor, a flow regulator, a flow deflector, and a combinationof the above. The filling compartment may be at least partially definedby a well, compartment or cavity pre-formed in at least one of the firstand second package walls of the package. A filling system may beconfigured to communicate with the filling compartment through afluid-tight seal. The fluid passageway may be formed to direct fluid tothe package along the first package wall of the first compartment toprevent jetting, bubbles and foaming. The cartridge may include a gasevacuation compartment in communication with the first compartment via afluid evacuation passageway, wherein the fluid evacuation passageway issealable to hermetically seal the package after filling. At least aportion of the package may include a tubular construction. The fitmentmay be configured to guide the package toward interfacing with thefillable reservoir. The guidance may be a linear guidance. The cartridgemay include a closure segregating the first compartment from the fitmentuntil opened. The cartridge may include a backing to support at least aportion of the package.

Another aspect of the present disclosure relates to an aseptic cartridgefor use with a beneficial agent delivery device having a fillablereservoir. The cartridge includes a package having at least a firstcompartment and a fitment. The first compartment contains at least oneconstituent of the beneficial agent, and the package is at leastpartially defined by a pre-formed flexible wall. The fitment is disposedon the package for interfacing the package in fluid communication withthe fillable reservoir.

The package may include the first compartment containing a firstconstituent of the beneficial agent, and a second compartment containinga second constituent of the beneficial agent, wherein the secondcompartment is segregated from the first compartment by a rupturablebarrier also referred to as a closure, or a frangible seal. At least aportion of the flexible wall may include a foil or film, generallyreferred to as web or webbing. At least a portion of the flexible wallmay include a peelable foil layer. At least a portion of the peelablefoil layer may be pre-formed. The cartridge may include a fluidpassageway extending between the first and second compartments. Thecartridge may include a static mixer disposed in the fluid passageway.The cartridge may include a fluid passageway located between the packageand the delivery device, and a static mixer is disposed in the fluidpassageway. The package may include a flexible wall that extends to format least a portion of an aseptic closure to the fitment.

The cartridge may include a filling compartment, a fluid fillingpassageway, wherein the filling compartment is in fluid communicationwith the first compartment via the fluid filling passageway. Thecartridge may include first and second package walls, and the fillingcompartment may be located between the first and second package walls.The fluid filling passageway may be sealable. The fluid fillingpassageway may be sealable to hermetically seal the package afterfilling and to prevent backflow to the filling compartment during orafter filling. The fluid filling passageway may be sealed by thermallysealing between the first and second package walls. The cartridge mayinclude an insert disposed in at least one of the filling compartmentand the fluid filling passageway. The insert may include at least one ofa valve, a check valve, an isolation valve, a flow restrictor, a flowregulator, a pressure restrictor, a pressure regulator, a flowdeflector, a nozzle, a stopper, and a seal. The insert may provide atleast a portion of a flow control device such as a valve, a check-valve,a flow restrictor, a flow regulator, a flow deflector, and a combinationof the above. The filling compartment may be at least partially definedby a well pre-formed in at least one of the first and second packagewalls. The filling compartment may be configured to communicate with afilling system through a fluid-tight seal. The fluid filling passagewaymay direct fluid to the package along a first package wall to preventjetting, bubbles or foaming. The cartridge may include a gas evacuationchamber in communication with the first compartment via a scalable fluidevacuation passageway to hermetically seal the package after filling.The cartridge may include a closure segregating the first compartmentfrom the fitment until opened. The cartridge may be configured tocontain a unit-dose of an injectable product or at least one constituentthereof. The fitment may be configured to guide the package towardinterfacing with the fillable reservoir. The guidance may be a linearguidance. The cartridge may include a backing to support at least aportion of the package.

A further aspect of the present disclosure relates to a cartridge foruse with a beneficial agent delivery device having a fillable reservoir.The cartridge includes a backing and a package assembly. The packageassembly includes at least a first compartment and a fitment. The firstcompartment contains at least one constituent of the beneficial agentand is at least partially defined by a flexible wall. The fitment isdisposed on the package for interfacing the package in fluidcommunication with the fillable reservoir.

The cartridge and the delivery device may be joined via the backing. Thebacking may include a fluid passageway interconnecting the cartridge andthe delivery device. The fluid passageway may be aseptically sealed. Thefluid passageway may include a closure separating the first compartmentfrom the reservoir until opened. The cartridge may include a rupturablebarrier between the first compartment and the fitment. The packageassembly may include at least a second compartment containing at least asecond constituent of the beneficial agent, wherein the secondcompartment is separated from the first compartment by a rupturablebarrier. At least a portion of the flexible wall may include a foil. Theflexible wall may be pre-formed to define at least a portion of thefirst compartment. At least a portion of the flexible wall includes apeelable foil layer. At least a portion of the peelable foil layer maybe pre-formed. The cartridge may include a fluid passageway positionedbetween the first and second compartments. The cartridge may include astatic mixer disposed in the fluid passageway. The cartridge may includea static mixer disposed in a fluid passageway that is positioned betweenthe package assembly and the delivery device. The flexible wall mayextend to form at least a portion of an aseptic closure to the fitment.

The cartridge may include a filling compartment, a fluid fillingpassageway, wherein the filling compartment is arranged in fluidcommunication with the first compartment via the fluid fillingpassageway. The cartridge may include first and second package walls,and the filling compartment may be located between the first and secondpackage walls. The fluid filling passageway may be sealable. The fluidfilling passageway may be sealable to prevent backflow to the fillingcompartment after filling. The fluid filling passageway may be sealed bythermally sealing between the first and second package walls. Thecartridge may include an insert disposed in at least one of the fillingcompartment and the fluid filling passageway. The insert may include atleast one of a valve, a check valve, an isolation valve, a flowrestrictor, a flow regulator, a pressure restrictor, a pressureregulator, a flow deflector, a nozzle, a stopper, and a seal. Thefilling compartment may be at least partially defined by a well formedin at least one of the first and second package walls. The cartridge mayinclude a filling system configured to communicate with the fillingcompartment via a fluid-tight seal. The fluid filling passageway maydirect fluid held by the package along a first package wall to preventjetting. The cartridge may include a gas evacuation chamber incommunication with the first compartment via a fluid evacuationpassageway, wherein the fluid evacuation passageway is sealable toprevent flow from the first compartment after filling. The deliverydevice may be selected from the group consisting of a medical syringe,staked needle syringe, safety syringe, retractable needle syringe,auto-disabling syringe, auto-injector, jet-injector, intradermalsyringe, subcutaneous syringe, intramuscular syringe, infusor, infusionpump, sustained release delivery system, and patch pump.

The cartridge may be configured to communicate with an administrationportion of the delivery device. The administration device may beselected from a needle, a canula, a catheter, a connector, a Luerconnector, a nozzle, a spray nozzle, a jet nozzle, a dispenser, an oraldispenser, a auricular dispenser, an ocular dispenser, a topicaldispenser, or a coupler to the one of the above.

Another aspect of the present disclosure relates to a cartridge for usewith a beneficial agent delivery device having a fillable reservoir andan administration device. The cartridge includes a coupler and a packagehaving at least a first compartment and a fitment. The first compartmentcontains at least one constituent of the beneficial agent. The fitmentis disposed on the package. The coupler is joined to the delivery devicefor interfacing the fitment in fluid communication with the fillablereservoir.

The coupler may include at least one closure interrupting the fluidcommunication until opened. The coupler may be movable relative to atleast one of the fitment and the delivery device from a first positionwhere said closure is interrupting said fluid communication to a secondposition where the closure is opened. The coupler may be asepticallysealed. The coupler may include an injection needle interfaceable withthe delivery device. The coupler may include a membrane interrupting thefluid communication, wherein the membrane is pierceable by a tip of theinjection needle. The injection needle may be movable from a firstposition wherein the membrane is not pierced to a second positionwherein the membrane is pierced. The coupler may be configured tocommunicate with an administration device. The coupler may include avalve controlling the flow into and out of the package. The valve may beoperative by a relative motion between the fitment and the coupler. Atleast a portion of the package may be detachable from the coupler. Thepackage may be detachable from the coupler after the reservoir has beenat least partially filled with the beneficial agent. The coupler mayinclude a safety device from a group consisting of a needle stickprevention device and a reuse prevention device, wherein the safetydevice is joined with the delivery device when a portion of thecartridge is removed from the delivery device. The cartridge may includea backing for the package. The coupler may be configured as a cap of atleast one of the delivery device and the administration device. Thedelivery device may be selected from a group consisting of a medicalsyringe, staked needle syringe, safety syringe, retractable needlesyringe, auto-disabling syringe, auto-injector, j et-injector,intradermal syringe, subcutaneous syringe, intramuscular syringe,infusor, infusion pump, sustained release delivery system, and patchpump. The administration device may be selected from a group consistingof a needle, a catheter, a connector, a Luer connector, a nozzle, a jetinjector nozzle, a dispenser, a micro-needle, an ID needle, an IMneedle, a SQ needle, an oral dispenser, an ocular dispenser, anauricular dispenser, a topical dispenser, and a coupler to one of theformer. The coupler may include at least a portion of a syringe piston.The coupler may include at least a portion of a syringe barrel. Thecoupler and fitment may be joined by at least one of a press fit, athermal weld, and a bonding. The delivery device may include a syringeand the administration device may include a needle, and the coupler maybe configured to join the needle with the fitment. The coupler may beconfigured to guide the needle and the fitment toward joining. Thecoupler may provide a needle protector. The coupler may provide anaseptic closure for the needle that is maintained until the cartridgeand syringe are joined.

The coupler may be configured to communicate with a syringe of adelivery device that comprises a needle, and to be joined with thefitment when the package is joined with the syringe. The delivery devicemay include a needle protector that is removable when the package andsyringe are joined. The delivery device may include an aseptic closurefor the needle that is maintained until the package and syringe arejoined. The coupler may be configured to fix a position of a tip of theneedle. The cartridge may include a glider disposed in an inner bore ofthe coupler, wherein at least a portion of the glider is axially movablebetween a distal tip of the needle and a proximal end of the needle. Thecoupler may remain joined with the fitment when the cartridge is removedfrom the syringe. The coupler may remain joined with the delivery devicewhen the cartridge is removed from the syringe.

The cartridge may include a fluid passageway for fluid communicationbetween the package and the reservoir, wherein the fluid passageway isterminated by a membrane that is pierceable by an injection needle. Thepackage may include at least one flexible wall that is pre-formed todefine at least a portion of the first compartment. The package mayinclude at least one flexible wall having a peelable foil layer portion.At least some of the peelable foil layer may be pre-formed. Thecartridge may include a fluid passageway located between the firstcompartment and a second compartment of the package. The cartridge mayinclude a static mixer disposed in the fluid passageway. The cartridgemay include a fluid passageway positioned between the package and thedelivery device, and a static mixer disposed in the fluid passageway.The package may further include a flexible wall that extends to form atleast a portion of an aseptic closure to the fitment.

The cartridge may include a filling compartment, a fluid fillingpassageway, wherein the filling compartment is arranged in fluidcommunication with the first compartment via the fluid fillingpassageway. The cartridge may include first and second package walls,and the filling compartment may be positioned between the first andsecond package walls. The fluid filling passageway may be sealable. Thefluid filling passageway may be sealable to prevent backflow to thefilling compartment after filling. The fluid filling passageway may besealed by thermally sealing between the first and second package walls.The cartridge may include at least one insert disposed in at least oneof the filling compartment and the fluid filling passageway. The insertmay include at least one of a valve, a check valve, an isolation valve,a flow restrictor, a flow regulator, a pressure restrictor, a pressureregulator, a flow deflector, a nozzle, a stopper, and a seal. Thefilling compartment is at least partially defined by a well formed in atleast one of the first and second package walls. The cartridge mayinclude a filling system configured to communicate with the fillingcompartment through a fluid-tight seal. The fluid filling passageway maydirect fluid held by the package along a first package wall to preventjetting. The cartridge may include a gas evacuation chamber incommunication with the first compartment via a fluid evacuationpassageway, wherein the fluid evacuation passageway is sealable.

A further aspect relates to a cartridge for use with a beneficial agentdelivery device having a fillable reservoir. The cartridge includes apackage containing all of a beneficial agent dose or all constituentsthereof. The cartridge includes a package comprising at least a firstcompartment containing all of the beneficial agent or at least oneconstituent thereof, wherein the first compartment is at least partiallydefined by a flexible wall. The package also includes a fitment disposedon the package for interfacing the package in fluid communication withthe fillable reservoir. The beneficial agent delivery device may providea unit dose. The beneficial agent delivery device may include a unitaryreservoir.

The dose may be an injectable dose. The injectable dose may be largerthan 0.1 ml and smaller than 5 ml. The injectable dose may be largerthan 0.3 ml and smaller than 3 ml. The fitment may be configured toguide the cartridge toward interfacing the unit dose package in fluidcommunication with the fillable reservoir.

A further aspect relates to a pre-filled cap for enclosing anadministration portion of a unit dose beneficial agent delivery devicecomprising a unitary reservoir. The pre-filled cap includes at least afirst compartment containing at least one constituent of the beneficialagent, and a fluid passageway for communicating the first compartmentwith the administration portion.

The first compartment may include a wall, and at least a portion of thewall comprises a flexible material. The flexible material may include awebbing. The first compartment may include a first constituent of thebeneficial agent, and further includes a second compartment containing asecond constituent of the beneficial agent, and an openable closureseparating the first and second constituents. The administration portionmay include one of a needle, a catheter, a connector, a Luer connector,a nozzle, a jet injector nozzle, a dispenser, a micro-needle, an IDneedle, an IM needle, a SQ needle, an oral dispenser, an oculardispenser, an auricular dispenser, a topical dispenser, and a coupler toone of the former. The administration portion may be configured tointerface with a delivery device from the group of a medical syringe,staked needle syringe, safety syringe, retractable needle syringe,auto-disabling syringe, auto-injector, jet-injector, intradermalsyringe, subcutaneous syringe. intramuscular syringe, infusor, infusionpump, sustained release delivery system, and patch pump.

The pre-filled cap may include a closure that separates the firstcompartment and the administration portion until the closure is opened.The cap is movable relative to at least one of the package and theadministration portion from a first position to a second positionthereby opening said closure. The pre-filled cap may include a fluidpassageway. The pre-filled cap may include a membrane occluding thefluid passageway. The administration portion may include a needle thatis movable to pierce the membrane to establish fluid communication withthe fluid passageway. The administration portion may include a needleconfigured to pierce the membrane to establish fluid communication withthe fluid passageway. The pre-filled cap may include a backing for atleast a portion of said package. The first compartment may be formed ina package that includes a fitment. At least a portion of the package mayinclude a webbing. The administration portion may be aseptically sealedin the cap. At least a portion of the administration portion isprotected by the cap.

Another example beneficial agent unit dose dispenser, in accordance withthe present disclosure, includes a delivery device and a cartridge. Thedelivery device has a fillable unit dose reservoir and at least one portin communication with the fillable reservoir. The cartridge isconfigured to aseptically join to the delivery device and includes aunit dose package. The unit dose package includes at least a firstcompartment, a fitment, and an openable seal. The first compartmentcontains at least one constituent of the beneficial agent, and thepackage is at least partially defined by a flexible wall. The fitment isjoined with the unit dose package and interfaces the unit dose packageto the delivery device. The openable seal is disposed between the firstcompartment and the reservoir.

The reservoir may be substantially empty prior to use. The reservoir maycontain at least one constituent of the beneficial agent.

Another aspect of the present disclosure relates to a pre-filled syringefor dispensing a beneficial agent. The pre-filled syringe includes apiston assembly, a fillable barrel comprising an administration portionand a portion for receiving the piston assembly, and a pre-filledcartridge comprising at least a first compartment containing at least afirst constituent of the beneficial agent, and a flow passageway forcommunicating contents from the first compartment to the barrel.

The administration portion may include one of a needle, an IM needle, amicro-needle, an ID needle, a SQ needle, an IM needle, a safety needle,a retractable needle, a needle with a protective sleeve, a nozzle, a jetinjection nozzle, a dispenser, and an applicator. The pre-filled syringemay include a cap sealing the administration portion, wherein thecartridge is integrated with the cap. The pre-filled syringe may includea flow passageway that communicates with the barrel via theadministration portion. The barrel may include at least a secondconstituent of the beneficial agent. The pre-filled syringe may includea closure separating the first compartment from the barrel until opened.The cartridge may be movable to open the closure. The pre-filled syringemay be configured for manual operation. The pre-filled syringe may beconfigured to be operated by at least one of an auto injector, a syringepump, a controlled actuator, a mechanical ram or pressure. A proximalend of the barrel may be aseptically sealed.

A further aspect of the present disclosure relates to a cap for anadministration portion of a delivery device. The cap comprises a fluidpassageway, a proximal end configured to communicate with theadministration portion, and a distal end.

The cap may include an adapter positioned at the distal end of the fluidpassageway for communicating with a pre-filled package. The adapter maybe configured to communicate with a fitment of the pre-filled package. Aclosure may be disposed in the fluid passageway and configured toseparate the distal end and the proximal end of the fluid passagewayuntil opened. The cap may be movable to open the closure. The proximalend may be configured to communicate with the administration portion viaa coupler. The cap may be configured to seal to the administrationportion. The cap may be configured to maintain the administrationportion aseptically sealed. The cap may include a backing to support apre-filled package.

An example method, in accordance with the present disclosure, relates toa method for forming a pre-filled package of a beneficial agent. Themethod includes providing a webbing having a first side and a secondside joined together to form a boundary of at least a first constituentcompartment therebetween, forming a frangible seal along at least aportion of the boundary, forming a permanent seal such that thepermanent seal overlaps at least some of the frangible seal to create anoverlapped portion having substantially the same sealing properties asthe permanent seal, and filling the first constituent compartment.

The frangible seal may be formed along the entire boundary. The methodmay include filling the first constituent compartment with at least thefirst constituent of the beneficial agent prior to forming the frangibleseal. The first constituent compartment may be filled with at least afirst constituent of the beneficial agent after forming the frangibleseal and prior to forming the permanent seal. The method may includeforming a filling access for the first constituent compartment, and thepermanent seal seals the filling access. The frangible seal may exhibita first peeling strength characteristic and the permanent seal mayexhibit a second peeling strength characteristic, wherein the first andsecond peeling strength characteristics are derived by a sealing settingof sealing equipment used to form the frangible and permanent seals. Thefrangible seal may exhibit a first peeling strength characteristic andthe permanent seal may exhibit a second peeling strength characteristic,wherein the first peeling strength characteristic is attributed to alocal sealing property of the webbing. The second seal may overlap amajority of the frangible seal. The boundary may define at least asecond compartment, and wherein a frangible seal section remains betweenthe first and second compartments after the permanent seal is formed.The method may include providing an outlet port and a passageway to theoutlet port that is defined by the permanent seal, wherein a frangibleseal section remains between the first constituent compartment and theoutlet port.

Another example method in accordance with the present disclosure relatesto a method of forming a pre-filled package of a beneficial agent. Themethod includes forming a gas-filled compartment for the beneficialagent, and forming a filling compartment having a filling portcommunicating with the gas-filled compartment via a first sealablechannel. The method also includes coupling a source of at least a firstconstituent of the beneficial agent with the filling port in afluid-tight fashion, filling the gas-filled compartment from the sourcevia the filling channel while evacuating gas through the exhaust port,and sealing the first sealable channel and the filling channel.

The method may include forming an exhaust compartment having an exhaustport communicating with the gas-filled compartment via a second sealablechannel. Filling the gas-filled compartment from the source via thefilling channel may be done while evacuating gas through the evacuationport. At least a portion of one of the gas-filled compartment, thefilling compartment, and the first sealable channel may be pre-formed.The method may include trimming the pre-filled package to remove atleast one of the filling and exhaust ports. At least a portion of thepre-filled package may include a webbing. The webbing may be pre-formedto define a volume of the gas-filled compartment. The pre-filled packagemay be accommodated in a cavity during filling to further accuratelydefine a volume for the gas-filled compartment. A vacuum may be appliedto the cavity. During filling, the pre-filled package may be positionedsuch that the second sealable channel is elevated relative to the firstsealable channel. The filling port may include a well. The method mayinclude disposing at least a first insert in at least one of the firstcompartment, the first channel, and the second channel. The insert mayinterface with the source of the first constituent. The interface mayinclude a valve. The filling compartment and the first sealable channelmay be hermetically sealed from the environment prior to the fillingstep.

The method may include, prior to filling, piercing a wall of the fillingport to receive the source of the first constituent. The source of thefirst constituent may include a capillary tube terminating with apiercing element. The capillary tube may pierce a web wall of thefilling port, wherein the web forms a fluid-tight seal with the fillingtube. The method may include stacking a plurality of the pre-filledpackages and transporting the stacked pre-filled packages to a fillingmachine. The method may include sterilizing the package after thecompartment forming step and prior to the filling step. At least one ofthe first scalable channels may include a scalable insert. The firstfillable channel may be made such that during the filling step the firstconstituent flows along a wall of the filling compartment to preventjetting, foaming, or bubbles.

The method may include providing a sensor for detecting presence of theconstituent in the second scalable channel, and indicating with thesensor that the filling compartment is filled. The source of the firstconstituent may include a metering pump. The source of the firstconstituent may include a non-metering pumping system. The pre-filledpackage may include an evacuation line for receiving the gas evacuatedthrough the evacuation port. The method may include applying a vacuum atthe evacuation port. The first constituent may include solid matter froma group consisting of powder, pellets, granules, tablets, aglomerats,spheres and micro-spheres. During the filling step, the firstconstituent may be transported to the first compartment with a gas flow.A size of at least one opening of the second scalable channel may limitthe first constituent from exiting the evacuation port. The pre-filledpackage may be manufactured on a form-fill-seal line. A plurality of thepre-filled packages may be manufactured from a single web member. Thesource of the first constituent may be attached to the filling portusing vacuum. At least one of the filling compartment and the sealablechannels are molded to shape. The gas-filled compartment may bepre-formed to define substantially the fill volume of the beneficialagent.

A further method in accordance with the present disclosure relates to amethod of producing a unit-dose delivery system for a beneficial agentthat includes receiving an assembled delivery device, receiving apre-filled, aseptically sealed cartridge which has been pre-filled withat least a first constituent of the beneficial agent, and integratingthe delivery device and the aseptically sealed cartridge.

The delivery device may be a syringe comprising a piston preassembled toa barrel. The delivery device and cartridge may be pre-sterile, and themethod further includes aseptically integrating the delivery device andcartridge. The method may include terminally sterilizing the deliverydevice after integration.

Another example method relates to filling a package with a unit-dose ofbeneficial agent in a liquid state. The method includes freezing ametered unit-dose of the beneficial agent in a mold to create a frozendose, placing the frozen dose in a semi-finished compartment, andsealing the compartment.

The package may include a blister pack and the frozen dose is placed ina pre-formed cavity in the blister pack. The method may includeinspecting the frozen dose for at least one controlled property prior toplacing the frozen dose in the compartment. The method may includemanufacturing the package from at least a first web material andfreezing the unit-dose onto the first web material. The method mayinclude thawing the frozen dose after sealing the compartment. Themethod may include exposing the frozen dose to a temperaturesufficiently low to prevent thawing prior to sealing the compartment.

Another example method relates to filling a package with a metered doseof at least a first constituent of a beneficial agent in a particulatesolid material form. The method includes metering a dose of the firstconstituent, compressing the metered dose enough to form a unitary body,placing the unitary body in a semi-finished package, sealing thepackage, and directing energy at the unitary dose through a wall of thepackage to deagglomerate the unitary body.

The method may include inspecting the unitary body to at least onecontrolled property prior to placing the unitary body in the package.The package may be made at least partially from at least a first web,and the method includes compressing the unitary body onto the first web.The method may include forming the package on a form-fill-seal line. Atleast a portion of the package may include a web material and the energyis directed by depressing the unitary body through a flexible wall ofthe package. The energy may be directed to the unitary body by at leastone of mechanical vibration, ultrasonic vibration, audio vibration andRF vibration.

Another aspect of the present disclosure relates to a coupler forfacilitating the integration of a dispensing device and a cartridge. Thedispensing device includes a reservoir and an administration device, thecartridge includes a package containing content of at least a firstdispensable product, or at least a first constituent thereof, and afitment for connecting the cartridge in communication with theadministration device to allow for transfer of said content or at leastfirst constituent thereof to said reservoir. The coupler includes afirst end and a second end, wherein the first end being configured toreceive the administration device, and the second end is configured tomovably receive the fitment and guide the fitment into engagement withthe administration device so that the cartridge and the dispensingdevice are in fluid communication.

The coupler may include a glider movable within the coupler, wherein theglider holds the distal end of the administration device in apredetermined first position in the coupler, and moves toward a secondposition wherein the glider provides clearance for the fitment to engagewith the administration device. The glider may provide a fluid-tightseal with at least one of the administration device, the coupler, andthe fitment. The glider may aseptically seal the administration devicein the coupler. The glider may aseptically seal the reservoir. Theglider may be biased to the first position. The coupler may provide aphysical shield to the administration device.

The coupler may engage with at least one of the cartridge and thedispensing device via at least one of a press-fit, snap-fit, threadedengagement, a bionet, a helical connection, or an elevated ramp. Thecoupler may be configured to remain joined with the cartridge when thecartridge is disengaged from the dispensing device. The coupler may beconfigured to remain joined with the dispensing device when thecartridge is disengaged from the dispensing device. The administrationdevice may be a needle and the coupler provides a needle shield.

A further aspect relates to a medical syringe that includes anadministration needle at a distal end of the syringe, and a couplerreceived at the distal end. The coupler is configured to receive acartridge and guide the cartridge to an engagement position with theneedle. The coupler may be configured to shield the needle from physicaldamage. The coupler may be configured to aseptically seal the needle.The coupler may further include a glider movable within the coupler,wherein the glider holds the tip of the needle in a predetermined firstposition, and moves toward a second position wherein the glider providesclearance for the cartridge to engage with the needle. The glider may beconfigured to seal with at least one of the needle, the coupler, and thecartridge. The glider may be biased to the first position by a spring.At least a portion of the coupler may be removable from the syringe whenthe cartridge is disengaged.

Another example method of the present disclosure relates to a method forengaging a pre-filled cartridge with a dispensing device fortransferring fluidic content therebetween. The dispensing deviceincludes a reservoir, an administration device, and a coupler, whereinthe reservoir holds a content, and the administration device receivesand dispenses the content. The content may be a dispensable product orone or more constituents thereof. The coupler comprises a first end anda second end, wherein the second end movably receives a fitment to guidethe fitment into engagement with the administration device to providefluid communication between the cartridge and the dispensing device. Thefitment communicates the content with the reservoir. The method includesreceiving the cartridge in the coupler such that the cartridge and thedispensing device engage in fluid communication.

The method may include allowing fluid transfer between the cartridge andthe reservoir. The method may include disengaging the cartridge from thedispensing device. The method may include at least partially removing atleast a portion of the coupler from at least a portion of theadministration device. The method may include disengaging the cartridgefrom the dispensing device, wherein at least a portion of the coupler isremoved using the cartridge. The dispensing device and the coupler maybe sterile, the cartridge may be sterile. and the dispensing device andthe cartridge are aseptically engaged to form a sterile pre-filleddispensing system. The first end of the coupler may be configured toreceive the administration device, and the method includes mounting thecoupler on the dispensing device such that the administration device isreceived in the coupler. The method may include dispensing the contentfrom the dispensing device after at least a portion of the coupler hasbeen removed.

Another example method relates to a method for producing a prefillablecontainer. The method includes forming a sealed cavity comprising atleast a first compartment and at least a first filling compartmentinterconnected in fluid communication via a sealable first fillingchannel, piercing a wall of the filling compartment with a fillingdevice and filling a constituent into the first compartment via thefirst filling channel, and sealing the channel when the filling step iscompleted.

The method may include removing a portion of the container thatcomprises the filling compartment. The cavity may include at least asecond filling compartment interconnected in fluid communication withthe first compartment, and the method further includes piercing the wallof the second filling compartment to allow gas to evacuate from thefirst compartment while the first compartment is filled with theconstituent, and sealing the second channel when the filling iscompleted. The container may include a first pre-formed web wall joinedwith a second wall to define the sealed cavity. At least one wall of thecontainer may be molded from plastic material. The container may be blowmolded.

A further aspect of the present disclosure relates to a cartridge foruse with a beneficial agent delivery device having a fillable reservoir.The cartridge includes a package including at least a first compartment,wherein the first compartment includes a first wall having a pre-formedpeelable layer.

The peelable layer may include a planar area along a peripheral edge ofthe compartment for joining the peelable layer to the first wall. Thefirst wall may be pre-formed to define a cavity, and the pre-formedpeelable layer is configured to contain the cavity. The peelable layermay be a portion of the first wall construction.

Another aspect relates to a dispensing package that includes first andsecond web walls, first and second compartments, a frangible seal, and adispensing port. The first web wall and a second web wall are joinedalong peripheral edges to define at least a portion of a compartmentboundary. The first compartment contains at least a first constituent ofa dispensable product. The second compartment contains at least a secondconstituent of a dispensable product. The frangible seal is positionedbetween the first and second compartments, which when opened allows thefirst and second constituents to merge. The dispensing port is opened inat least the first web wall. The frangible seal segregates the first andsecond compartments from the dispensing port. When the frangible seal isruptured, fluid communication is established between the first andsecond constituents and the dispensing port. The first and secondcompartments may be formed in the second web wall.

Another aspect relates to a cap for an administration device of adelivery device. The cap includes a first compartment configured toreceive the administration device, a second compartment, and a barrierforming a fluid tight seal between the first and the second compartment.

The first compartment may include a proximal end configured tocommunicate with at least one of the delivery device and theadministration device. The second compartment may interface incommunication with a fluid passageway. The second compartment may beconfigured to receive the distal portion of the administration device.The barrier may be configured to tightly seal around an area of theadministration device between the proximal end and a distal end of theadministration device. The cap may include an adapter in communicationwith the second compartment for communicating with a pre-filled package.The adapter may be configured to communicate with a fitment of thepre-filled package. The cap may include a fluid passageway and a closuredisposed in the fluid passageway and configured to separate a distal endand a proximal end of the fluid passageway until opened. The proximalend may be configured to communicate with the administration device viaa coupler. The cap may be configured to seal to the administrationportion. The cap may be configured to provide protection to theadministration device. The cap may include a backing to support apre-filled package.

Another aspect of the present disclosure relates to a package thatincludes first and second web walls and a fitment. The first web walland second web wall are joined at a joint along peripheral edges to atleast partially define a compartment. At least one of the first and thesecond web walls is pre-formed to define a cavity in the compartment. Atleast a first portion of the joint provides a rupturable seal, whichwhen ruptured provides fluid communication with the fitment, and atleast a second portion of the joint provides a permanent seal.

The applications of the present invention are not limited to drugdelivery, which is provided herein by way of example. The teachingsdescribed herein can be applied to dispensing devices in other areassuch as, for example, glue dispensing, chemicals dispensing, etc. Thepresent disclosure provides various configurations for accomplishingthis.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1 a to 1 f illustrate an injector cartridge assembly with ablister package associated with its cap, which can be employed tovarious configurations.

FIGS. 2 a and 2 b illustrate a syringe assembly with a blister packageassociated with its cap, which can be employed to variousconfigurations.

FIGS. 3 a and 3 b illustrate a pre-filled syringe assembly with apackage associated with its piston's stem, and extending axially fromit, which can be employed to various configurations.

FIG. 4 illustrates a syringe assembly with a blister package associatedwith its stem, and extending laterally from it, which can be employed tovarious configurations.

FIGS. 5 a and 5 b illustrate a pre-filled cartridge in a spring poweredneedle-free auto injector.

FIG. 6 illustrates a pre-filled cartridge in a pyrotechnically poweredneedle-free auto injector.

FIG. 7 illustrates a cartridge made from an extruded tube.

FIG. 8 illustrates a cartridge made from extruded tube and loaded in aneedle-free auto-injector.

FIG. 9 a illustrates a cartridge made from extruded tube and mountedonto a syringe.

FIG. 9 b illustrates a cartridge made from extruded tube comprising apeelable protective foil and mounted on a syringe.

FIGS. 10 a to 10 e illustrate a cartridge with a peelable portion of theformed-wall and an extended wall portion forming an aseptic compartmentaround the dispensing port, and a number of operation steps.

FIG. 11 illustrates a cartridge with a peelable portion of the flatwall.

FIG. 12 illustrates a cartridge with a flanged dispensing port attachedto the external side of the wall of the cartridge.

FIG. 13 illustrates a cartridge associated with a valved-couplercommunicating to a syringe and a needle.

FIG. 14 illustrates a cartridge associated with the distal end of asyringe barrel.

FIG. 15 illustrates a semi-finished cartridge ready for lyophilizationof a beneficial agent.

FIG. 16 illustrates a cartridge comprising a static mixer at itsdispensing port facilitating the mixture of two constituents stored inthe cartridge.

FIG. 17 illustrates a system for mixing a first constituent contained ina cartridge and a second constituent contained in a syringe.

FIG. 18 illustrates a system for mixing a first constituent and a secondconstituent contained in a cartridge.

FIG. 19 illustrates a static mixer integrally formed in a blister-typecartridge.

FIGS. 20 a to 20 e illustrate a method for fabrication of the cartridge.

FIGS. 20 f and 20 g illustrate the frangible and permanent seal patternsof the cartridge of FIGS. 20 a to 20 e.

FIGS. 21 a to 21 e illustrate a syringe comprising a static mixer formixing a substance contained in a syringe with a substance contained ina cartridge.

FIGS. 22 a and 22 b illustrate a cartridge communicating with a stakedneedle syringe via a fitment.

FIGS. 23 a to 23 g illustrate a cartridge and a staked needle syringeattachable via a coupler.

FIGS. 24 a and 24 b illustrate another arrangement of a staked needlecoupler.

FIGS. 25 a to 25 c illustrate a cartridge comprising a couplercontaining an injection needle.

FIG. 25 d illustrates two sub-assemblies of the pre-filled cartridge ofFIGS. 25 a to 25 c.

FIG. 25 e illustrates an exploded view of a cap portion of the cartridgeof FIGS. 25 a to 25 c.

FIG. 26 illustrates a cartridge adopted for a syringe with anintradermal (ID) injection adapter.

FIGS. 27 a and 27 b illustrate a cartridge associated with an IDsyringe.

FIG. 28 illustrates another arrangement of a cartridge associated withan ID syringe.

FIGS. 29 a and 29 b illustrate another arrangement of a cartridgecomprising an ID needle arrangement.

FIG. 30 illustrates another arrangement of a cartridge comprising an IDneedle arrangement.

FIGS. 31 a and 31 b illustrate a cartridge comprising a needle safetyand disabling feature.

FIG. 32 illustrates a cartridge with a movable needle.

FIGS. 33 a to 33 e illustrate a pre-filled syringe arrangement.

FIG. 34 illustrates a cartridge with a backing and walls protecting thepre-filled package of the cartridge.

FIGS. 35 a to 35 f illustrate filling steps of one method of filling apackage.

FIG. 36 illustrates an arrangement of a portion of a package having afirst insert disposed in the filling compartment, and a second insertdisposed in the filling channel.

DETAILED DESCRIPTION

FIG. 1 a shows an arrangement of an injector 11 and a cartridge 10. FIG.1 b illustrates a section view of the injector assembly 11 and thecartridge 10. The injector 11 comprises a body 13 in the form of atubular shaped barrel and a piston 14 disposed in the body. The piston14 is movable along the axis of the body between a forward, empty state,and a retracted, filled state. The piston 14 further comprises an O-ringseal 14′, providing a fluid-tight seal between the body 13 and thepiston 14, and defining a dispenser reservoir or a reservoir in front ofthe piston for receiving an injectable dose. The reservoir is shown atthe emptied state, wherein the piston 14 is advanced to the forward mostposition in the body 13. A jet nozzle 17, at the front of the body 13,is configured to hypodermically deliver a dose to a subject in aneedle-free jet injection fashion when the piston 14 is advanced in thebody 13 to deplete the reservoir volume. Prior to injection, the jetnozzle 17 serves as a port for filling a fluid dose from the cartridge10 to the reservoir of the injector 11.

The cartridge 10 comprises a package comprising a first thin wall 18′,pre-formed to establish two cavities; and a second thin wall 18″ whichseals against the first thin wall 18′ to define a first sealedcompartment 15 and a second sealed compartment 16. A fitment 12 isdisposed on the package 10′, joined to the package 10′ between the firstwall 18′ and the second wall 18″. The fitment 12 is structured to engagewith the front of the injector body 13. A first frangible seal section19′, separates between the first compartment 15 and the secondcompartment 16, and is peelable by a defined threshold force to allowfluid the content of the first compartment 15 and the second compartment16 to merge. A second frangible seal 19″ separates between the secondcompartment 16 and the fitment 12, and is peelable (rupturable) at adefined threshold peeling force. The second frangible seal defines aclosure segregating the first compartment 15 from the fitment 12 untilopened. The first and second walls 18′, 18″ may be made from a type offilm or foil (together referred to as “web”, webbing, or “web material”)including extruded web, blown web, cast web, multilayer web, laminatedweb, coated web, webs including metallicized layers such as aluminumlayer, webs including metal oxide layers such as alumina or silica, andwebs including high barrier layer including Cyclic Olefin Polymer (COP),Cyclic Olefin Copolymer (COC), polychlorotrifluoroethylene (PCTFE), orEthylene Vinyl Alcohol (EVOH). The inner adhesive layer of the webmaterial may be made from Olefin ionomers, Ethylene-vinyl acetate (EVA),or other materials.

In some arrangements, the web comprises an inner adhesive layer that hasa controllable peeling force such that designated areas of thecircumferential seal around the compartment would have lower peelingforce than others, thus limiting the areas that will be ruptured when athreshold peeling force is applied to the seal area between the firstwall 18′ and the second wall 18″. One such adhesive layer is the ionomerbrand EZ Peel® (Bemis, Neenah, Wisconsin) which produces a peelable sealat a sealing temperature of 130° C., and a permanent non-peelable sealat a sealing temperature of 170° C., thus allowing improved control ofthe sealing properties by performing a two-stage welding process atdifferent temperatures. The peelable and non-peelable seals may bethermal seals having thermally sealed or thermally welded portions.

In some arrangements, the peeling force of the seal between the firstwall 18′ and the second wall 18″ is controlled in different areas of theseal by applying a registered adhesive pattern of one or more adhesivetypes. In one arrangement, at least two adhesive types with differentpeeling strength are registered to define permanent sealing areas andpeelable sealing areas. The fitment 12 may be made from an olefinpolymer that will have good adhesion to the inner layer of the web, suchas Polyethylene (PE). In some arrangements the fitment is attached tothe outer side of one of the first wall 18′ or the second wall 18″, anda through hole in the web communicates the content of the cartridge 10and the fitment 12. In this arrangement, the fitment material should becompatible for attachment to the web's outer layer material. The firstand second compartments 15, 16 may contain various substances. In oneembodiment, the first compartment 15 contains a first beneficial agent,or a constituent of such, in a diluent format, and the secondcompartment 16 contains a second beneficial agent, or a constituent ofsuch, in dry format, and the content of the two compartments needs to bemixed to form a dispensable product dose. In one embodiment, the firstcompartment 15 contains a dilutant such as saline or water forinjection, and the second compartment contains a vaccine in dry powderformat.

The content or the constituents in the first compartment 15 and thesecond compartment 16 may be in various forms including liquid, frozenliquid, gel, paste, slurry, solid, granules, pellets, micro-pellets,spheres, micro-spheres, flowable powder, compressed powder, a cake, alyophilized cake, or other forms of solid matter known in the art. Whenthe first compartment contains a fluidic material, the first frangibleseal 19′ may be separated by depressing the first compartment 15 andpressurizing the content, thereby applying force to the first frangibleseal 19′ and peeling apart the seal, creating a joined compartmentbetween the first compartment 15 and the second compartment 16, andallowing the content of the two compartments to mix. The secondfrangible seal 19″ may be ruptured by depressing the joined compartmentand pressurizing its content thereby causing a peeling force to thesecond frangible seal 19″. The wall of the package 10′ may be extendedto provide a printable, or otherwise markable, surface, includinggraphics, text, barcode or other optical machine-readable representationof data (including RFID circuit), which shows data about the content ofthe cartridge, operation instructions, warnings, etc.

FIG. 1 c shows the cartridge 10 mounted onto the injector 11. Thefitment 12 is engaged with the front end of injector body 13, preferablycreating an aseptic zone within the fitment area. A passageway offitment 12 and the nozzle 17 are in fluid communication. For parenteralhypodermic drug delivery applications, all of the areas of the devicethat come in contact with the deliverable substances and the areas thatwill come in contact with the body of the subject are preferablymaintained sterile or uncontaminated until the time of use. In thearrangement of FIG. 1 c , the aseptic engagement of the injector 11 andthe cartridge 10 maintains the sterility to that area. The sterility ofthe inner side of the barrel 13 may be maintained through an asepticbarrier at the back end of the body 13, a local overwrap of portions ofthe back of the body 13 and the piston 14, or a sterile overwrap to theentire device. In some arrangements the injector 11 and the cartridge 10are provided separately, similar to the configuration shown in FIG. 1 bwith the addition that aseptic covers would be sealing the front area ofthe injector body 13 and the fitment 12.

The sterility of the fitment 12 may be achieved with a lead or a capprotecting the port area. A foil lead may be heat-sealed to thecircumference of the vertical walls around the port. In one embodiment,the cartridge 10 is stored in a sterile overwrap. In some arrangements,wherein at least one of the substances is in dry format, it may beadvantageous to include a drying agent such as a desiccant capsule,pellets, or gel in the sterile overwrap to avoid moisture from migratingto the dry compartment across the wall of web (i.e. the first wall 18′).In one embodiment, the drying substance may be integrated in the web.This arrangement is sometime referred to as scavenger web. The sterilityof the front end of the body 13 in the arrangement of FIG. 1 b can beachieved in various ways, including a tight cap, a thermally sealed foilaround the nozzle 17 area, and by packaging the entire injector in asterile overwrap. The arrangement of FIG. 1 c may therefore beadvantageous to reduce the measures that need to be taken to maintainsterility of the product. Referring now to FIG. 1 d , the arrangement ofFIG. 1 c is shown after the first and second frangible seals 19′, 19″(see FIG. 1 c ) have been ruptured, and a joined compartment 16′ isformed in fluid communication with the passageway of fitment 12.

FIG. 1 e shows the arrangement of the previous FIG. 1 d when the piston14 is retracted from the body 13, thereby causing the fluid from thejoined compartment 16′ to flow into the unitary reservoir 13′ in theinjector 11.

FIG. 1 f shows the arrangement of the previous FIG. 1 e wherein thepiston 14 is in a fully retracted state. The joined compartment 16′ isfully depleted and its content is fully transferred to the reservoir 13′of injector 11. The cartridge 10 is removed and the injector 11, whichis now loaded with the deliverable product dose, is ready to use. Wherethe arrangement is such that the cartridge 10 is joined with theinjector 11 at the factory, the front portion of the injector is beingmaintained sterile until this point when the fitment 12 is removed. Thisarrangement may be advantageous compared to commercially availableproducts wherein the injector's application surface is exposed to anon-sterile field even before the injector filling step, therebyincreasing contamination risk to the subject.

The arrangement of FIG. 1 a-1 f is showing an aseptic filling procedureof a jet injector cartridge. Without departing from the scope of theinvention, similar arrangements are provided to fill other cartridges,dispensers, or drug delivery devices known in the art including, forexample, intramuscular, subcutaneous, or intradermal injectors, andtheir cartridges, topical applicators and their cartridges andreservoirs, infusion pumps, microinfusion pumps, metering pumps,non-metering pumps, infusers, micro-infusers, patch delivery devices,and their cartridges and reservoirs, infusion containers includinginfusion bags and infusion bottles, oral, ocular, or ear dispensers andtheir cartridges and reservoirs, glue dispensers, and other dispensers,delivery device and applicators for various form of use and purpose.

FIG. 2 illustrates an arrangement of a pre-filled mixing cartridge 10and a regular syringe 20. The figure provides a section line of thesection view of FIG. 2 b . Referring to FIG. 2 b , the cartridge 10comprises a fitment terminating 21 with a Luer Lock female connector,coupled with a Luer Lock male connector of the syringe 20, and forming afluid-tight connection between the cartridge 10 and the syringe 20. Thefluid may be transferred from the cartridge 10 to the syringe 20 in thesame fashion as with the injector of FIG. 1 . The Syringe tip willremain in an aseptic environment until the time of use where thecartridge 10 will be removed. This arrangement may be advantageouscompared to commercial products where the syringe tip or the tip of aneedle of a syringe are exposed to a non-sterile field prior to thefilling step, which increases the risk of contamination to the subject.In one arrangement, the cartridge is maintained separate from thesyringe until the time of use, when they are integrated through the Luercoupling. The cartridge and syringe may be aseptically integrated. Tomaintain the sterility of the syringe 20 and the cartridge 10, similararrangements and measures may be taken as described above for thearrangement of FIG. 1 b.

Referring to FIGS. 3 a and 3 b , another arrangement is provided whereinthe cartridge 10 is connected to the back end of the piston 31 of asyringe 30 using a fitment 39. The piston 31 comprises a fluid passage32 along its axis, communicating a cartridge port 9 and the reservoir 35in the syringe body 33 (i.e. barrel). At the front end of the piston 31,a plunger 34 is arranged such that when the piston 31 is retracted, thefriction of the plunger 34 with the barrel 33 causes the plunger 34 toslightly displace away from the piston 31, thereby opening a fluid path35 (see arrow) allowing the content of the cartridge to transfer intothe barrel 33. A cap 37 maintains an aseptic space around the syringe'sdispensing tip 36. FIG. 3 b illustrates the arrangement of FIG. 3 aafter the piston 31 has been retracted to the fully retracted positionand is being advanced. The cartridge 10 is completely depleted of itscontent. The plunger 34 is replaced at the closer position to the piston31 head thereby sealing the passageway 32, such that the content of thebarrel 33 can only advance to the syringe tip 36 when the piston 31 isadvanced. Unlike commercial syringes where the dispensing tip or aneedle associated with it are exposed to a non-sterile field prior tothe filling process, in the current configuration the cap is removedfrom syringe tip 36 just prior to use and only after the fillingprocess. The cartridge may be coupled with the syringe by various meansknown in the art including, for example, Luer connector, barb connector,press fit connector, a septum and spike arrangement, a coupling tube, oradhered to each other. In one arrangement, the cartridge is disposedinside a hollow space in the piston.

Referring now to FIG. 4 , an arrangement is illustrated where thecartridge 10 is connected to the back end of the piston 43 using afitment 49 and extending in a lateral direction from piston 43. A valve44 is disposed at the back end of a fluid passageway 42 allowing fluidto transfer from the cartridge 10 to the barrel 40 and fill reservoir35, but prevents fluid from flowing in the opposite direction, thuscausing the entire dose to flow only to the dispensing tip 45 when thepiston is advanced. Valve 44 may be referred to as an isolation valveand may operate to separate or isolate the fill reservoir 35 and barrel40 from the cartridge 10. In one arrangement the valve 44 also allowsair into the flow passageway 42 after the cartridge 10 is emptied, thusadvancing the fluid from the passageway to the barrel. In oneembodiment, a dedicated aseptic compartment allows air or water into thefluid passageway 42 after the beneficial agent in the cartridge isemptied from the beneficial agent to wash the passageway from theresidual beneficial agent. In one arrangement the water or aircompartment is part of the cartridge 10 assembly. Other devices orstructures may be used to seal the passageway 42 beside the valve 44.The passageway 42 may be hermetically sealed. The passageway may besealed to prevent backflow of fluid into the water or air compartment.

In FIGS. 4 a, 4 b , and 5, the piston 43 serves as a coupler between thecartridge 10 and the reservoir. Generally these arrangements disclose acartridge 10 for use with a beneficial agent delivery device having afillable reservoir. The cartridge includes a package 10′ that includesat least a first compartment 15 containing at least one constituent of abeneficial agent, a fitment disposed on the package, and a coupler. Thecoupler is joined to the fitment for interfacing the package in fluidcommunication with the fillable reservoir. The coupler comprises aclosure interrupting the fluid communication until opened. The couplermay be aseptically sealed. The coupler is configured to communicate witha reservoir of an administration device. The coupler comprises a valvecontrolling the flow into and out of the package. The coupler comprisesat least a portion of a syringe piston. The coupler and fitment arejoined by at least one of a press-fit, a glued-fit, a thermal weld, anda bonding. The cartridge comprises a package that includes at least oneflexible wall that is pre-formed to define at least a portion of thefirst compartment.

FIG. 5 a illustrates a jet injector comprising a cartridge 10 comprisinga package 10′ disposed in a pressure chamber 51 in the injector body 52.The cartridge 10 comprises a needle-free jet nozzle 17 disposed on thepackage and associated with the front end of the injector body. A piston53 is disposed in the body 52 and is detained in its pre-use position bya detaining mechanism (not shown), and is biased forward to pressurizethe gas in the pressure chamber 51. In one arrangement, the cartridge 10comprises more than one compartment prior to use containing more thanone constituent, and those constituents are manually mixed by removingthe cartridge 10 and following a similar procedure as described in FIG.1 ; then replacing the cartridge 10 in the body 52.

FIG. 5 b shows the injector 50 after the piston 53 has been releasedfrom the detent mechanism and has been forced forward by spring 54 andpressurized the gas in the pressure chamber 51, thereby causing thecartridge walls to collapse and express the content of the cartridge 10through nozzle 17. The nozzle 17 may be protected by an aseptic cap oradhered foil until the time of use.

FIG. 6 shows a similar injector arrangement 60 to that of FIG. 5 withthe exception that the piston is biased forward by pressurized gas thatis generated by a pyrotechnic module 61 which is activated by manualswitch 62.

FIG. 7 shows a package 70 made from a tube section 71 that is pinchedand heat sealed 72 across the tube section 71 in a number of locations72 along the tube section 71 to form at least one compartment comprisinga beneficial agent or a constituent of such. In one configuration of thepackage 70, the seals at the pinching locations 72 are frangible sealsmade such that they will peel apart under the presence of thresholdpressure or force. The tube section 71 may be made by extrusion,injection molding, blow molding, rolling a flat foil and sealing theseam, or other manufacturing methods known in the art. In onearrangement, the tube section 71 comprises a number of layers, whereinthe inner layer is a heat sealing material and at least a second layerprovides improved barrier properties to reduce transfer of certain gasesor moisture across the tube wall. In one arrangement, the tube isco-extruded. In one arrangement, at least one first layer of the tubewall is made from a rolled sheet of plastic, metal, or metal oxide, andat least one second layer is extruded over the rolled first layer. Thewall of the package may be extended to provide a printable, or otherwisemarkable, surface, including graphics, text, barcode or other opticalmachine-readable representation of data (including RFID circuit), whichshows data about the content of the cartridge, operation instructions,warnings, etc.

FIG. 8 shows a needle free jet injector arrangement similar to thearrangement presented in FIG. 5 , with the exception that the cartridge80 comprises a package made from a tube section similar to the packageshown in FIG. 7 , and a jet nozzle 17 is attached at its front end.

FIG. 9 a shows a syringe and cartridge assembly similar to thearrangement presented in FIG. 3 , with the exception that the cartridge90 comprises a package 70 made from a tube section 93 that is pinchedand sealed across in first and second seals 99′, 99″ to form acompartment. First seal 99′ is a frangible seal that would rupture whenthe cartridge is compressed and the content is pressurized to allowfluid communication between the syringe and the cartridge. A female Luerlock connector 91 is attached at an end of the cartridge. In somearrangements, the cartridge 90 may be maintained separate from thesyringe until the time of use. Sterility of the product and the devicemay be accomplished in similar fashion and measures as described inFIGS. 1 to 3 above. The tube wall may incorporate a single layer ormulti-layers and may incorporate, for example, a high barrier PCTFElayer, an aluminum layer, a COC layer, and a peelable adhesive layer.

FIG. 9 b shows a further arrangement of a cartridge 90 comprising apackage 70 made from tube wherein a first seal 99′ and a second seal 99″define a first compartment 95 holding a first substance. A third seal99′″ defines a second compartment 94 holding a second substance tomerge. The first seal is rupturable to establish fluid communicationbetween the cartridge and a syringe 97. The cartridge further comprisespeelable high-barrier shells 96′ and 96″ sealed to each other and acrossthe first and second seals 99′, 99″. The peelable barrier shells 96′ and96″ enhance the barrier between the cartridge surrounding and the firstcompartment 95. This arrangement may be particularly advantageous wherethe barrier properties of the tube section 93 are insufficient toprotect the first compartment 95 from moisture, oxygen or lighttransmission.

The tube material may preferably be transparent to allow visualinspection of the contents, which generally comprise some of the barrierproperties. The peelable barrier shells 96′, 96″ may include a highbarrier aluminum layer that prevent visual inspection of the cartridgecontents, and hence the need to peel the shells for inspection. A firsttab 98′ and a second tab 98″ are provided as extensions to the first andsecond peelable barrier shells 96′ and 96″, respectively, to facilitatethe peeling of the shells with the fingers. The peelable barrier shellsmay be pre-formed to accommodate the shape of the first compartment 95.At least one of the peelable barrier shells 96′ and 96″ may be extendedto form a barrier shell to the second compartment 94. At least one ofthe peelable barrier shells may be extended to provide a printable, orotherwise markable, surface, including graphics, text, barcode or otheroptical machine-readable representation of the data (including RFIDcircuit), which shows data about the content of the cartridge, operationinstructions, warnings, etc. The peelable barrier shells may be madefrom a single of multi-layer film or foil (together “web”) and mayinclude a pressure sensitive adhesive, electrostatic adhesive ortemperature sensitive adhesive to form the peelable seal. FIG. 10 ashows another preferred cartridge arrangement 100 comprising a package100′ in which the second compartment 16 comprises a peelable layer 104.For various applications it is desired to have at least a portion of thepackage made from a clear material, for instance, in an applicationwhere it is desired to visually (or by optical instrumentation) inspectthe content of one or more compartments, or the merged compartment aftercombining the content of two or more compartments. However, clearmaterials typically have higher moisture vapor transmission rate (MVTR)than foils, which are opaque, thereby providing lower barrier betweenthe compartment(s) and the surrounding of the package. Some products areextremely sensitive to moisture, such as some vaccines in dry formatwith which potency may be compromised with relative humidity levelshigher than 2% or 3%. Visual inspection of the vaccine powder isimportant prior to use to ensure that the product has not been tamperedwith, and after mixing to inspect complete dissolution of the vaccinepowder with the dilutant.

In one arrangement, the cartridge 100 is stored in a desiccantcontaining overwrap, thereby keeping a dry environment around thepackage 101′. In one arrangement, the overwrap material is of the typeknown in the industry as “scavenger film” in which a desiccant substanceis embedded in the composition of the web material. In FIG. 10 a , thepowder compartment of the package 100′ comprises a peelable high-barrierpre-formed layer 104 that is opaque, or has limited or no opticaltransparency. In some arrangements, the peelable layer may provide abarrier from light. High barrier clear materials are typically morecostly than low barrier clear materials. In some arrangements, thelocalized, peelable layer 104 is made from high barrier clear materialsuch as a film containing Aclar (Honeywell), while the larger, formedfirst wall 18′ of the package 100 is made from a low barrier material toreduce manufacturing costs. The peelable layer 104 may provide otherdesired properties that the first wall 18′ lacks. The peelable layer 104may be part of the composition of the material of the first wall 18′.The peelable layer 104 may be made from a separate web of the first wall18′, and in one manufacturing arrangement, the two webs are formedtogether. In some arrangements, where the first wall 18′ is athermoformable film, and the peelable layer 104 is a cold-formed foil,the forming process may involve a step combining cold forming andthermoforming.

In some arrangements, a cavity 105 in the peelable layer 104 is formedseparate from the first wall 18′ and is subsequently attached to thepackage in a sealed fashion. Attaching the peelable layer 104 to thepackage may be achieved by one of the means known in the art including,for example, an adhesive, a glue, pressure sensitive adhesive, heatstake welding, ultrasonic welding, etc. In one arrangement, the peelablelayer 104 is sealed to the first wall 18′ via a die-cut adhesive sheet.The die-cut adhesive may be adhered to the first wall 18′, and at asubsequent stage the peelable layer 104 is attached to the die-cutadhesive. Alternatively, the die-cut adhesive may be adhered to thepeelable layer 104, and at a subsequent stage the first wall 18′ isattached to the die-cut adhesive. The peelable layer 104 may comprise analuminum lamination or aluminum coating.

The package arrangement 100 further comprises a fitment compartment 103maintaining the dispensing port in an aseptic enclosure until the timeof use. The fitment compartment 103 is formed in an extension 101 of theweb materials of the package 100. A tear-off notch 102 provides for aneasy removal of extension portion 101 to expose the fitment 12. FIG. 10b shows the cartridge arrangement 100 after the peelable layer 104 hasbeen removed, allowing for visual inspection of the content of thesecond compartment through the clear first wall 18′. In addition,extension 101 has been removed, exposing a fitment 12 (e.g., dispensingport) in the form of a female Luer Lock connector. In some procedures itwill be desired to merge the first and second compartments 15 and 16prior to removing extension 101 to minimize the exposure of thedispensing port and reduce the risk of contamination. The second wall18″ of the package 100 is preferably made from high barrier materialsuch as a laminated aluminum foil, SiOx laminate, AlOx laminate or othermaterials known in the art.

In some arrangements, the second compartment 16 is depressed to rupturethe first frangible seal 19′ between the first compartment 15 and thesecond compartment 16, to cause the two compartments to merge, and torupture the second frangible seal 19″ between the second compartment 16(or the merged compartment 15+16). The pre-formed structure of thesecond compartment 16 allows controlling the rupture of each of thefirst and second frangible seals 19′, 19″ at a desired sequence andtiming. The deep form of the second compartment 16 provides that whenthe second compartment 16 is depressed at its distal end 106, the strainin the area of the distal end 106 of the first wall 18′ 106 is relaxed,thus limiting the peeling force exerted on the second frangible seal 19″and preventing it from rupturing. Further, the proximal area 109 of thefirst wall 18′ opposite to the depression zone at the distal end 106, isstrained, and the first frangible seal 19′ is ruptured while the secondfrangible seal 19″ remains intact. At a subsequent step, the mergedcompartment (not shown) is pressed at its proximal area to exertsufficient peeling force on second frangible seal 19″ causing it torupture and establish fluid communication between the merged compartmentand the dispensing port. In addition to, or as an alternative to, theaseptic dispensing port compartment 103, the port may be asepticallysealed with, for example, a plug (such as a male Luer Lock cap), awelded foil portion, a stopper (such as a rubber stopper), or by anyother means known in the art. The second frangible seal may be avoidedif other closure features are aseptically protecting the content andpreventing the contents from spilling.

FIG. 10 c to FIG. 10 e show one method of operating the package 100′ toachieve a controlled and sequenced rupture of the first and secondfrangible seals 19′, 19″ by direct operation of the thumb of theoperator. The package 100′ is resting in the palm of the operator on theindex finger and the middle finger. In FIG. 10 c , the secondcompartment 16 is depressed by placing a thumb on its distal end 106. Asa result the first wall 18′ at the proximal area 109 of the firstcompartment 15 is strained, thereby exerting peeling force to the firstfrangible seal 19′. At the same time, the depression of the thumb on thedistal end 106 of the second compartment 16 prevents strains from thatarea of the first wall 18′, resulting in the peeling force on the secondfrangible section 19″ being eliminated or minimized. As a consequence(shown in FIG. 10 d ), the first compartment 15 and the secondcompartment 16 become joined compartment 16′ while the second frangibleseal 19″ remains intact, thereby allowing the constituents of the twocompartment to mix prior to communicating the dispensable product withthe fitment (i.e. dispensing port). The configuration of FIG. 10 dallows putting the cartridge aside, for example, in order to letsubstances mix properly without exposure to contamination risks as thedispensing port is still sealed in the dispensing port compartment 103and the joined compartment 16′ is still not in communication with thedispensing port.

In FIG. 10 e the dispensing port compartment has been tore off and thefitment or port 12 is engaged with a syringe 108. The joined compartment16′ is depressed with the thumb at its proximal area 109, causing thewall at the distal end 106 of the merged compartment 16′ to strain andexert peeling force on the second frangible seal 19″, and causing thesecond frangible seal 19″ to rupture and establish fluid communicationbetween the syringe 108 and the joined compartment 16′ via thedispensing port 12. In other arrangements, the depression of thecompartments 15, 16 is done by a compressing object such as a flat panelor a roller. This disclosure advantageously teaches a drug cartridge forfilling an injector where the fluid communication between the cartridgeand the injector is established only after the injector and thecartridge have been secured in a sealed tight fashion, limiting theexposure of the injectable product to a non-sterile field, and reducingthe risk of product spillage. Typically with vials and ampoules thefluid communication is established during the integration of theinjector and the cartridge by a spike penetrating a septum seal.

FIG. 11 shows an arrangement where the second wall 18″ of the packagecomprises a high-barrier peelable layer 111, providing enhanced moisturebarrier to the substances in the compartments. The first wall 18′ ispreferably made from a cold formed aluminum laminate providing a highbarrier to moisture and gases. A tab 112 provides an easier peel of thesecond wall 18″. In some arrangements, the peelable layer 111 isattached to the second wall 18″ by one of the means known in the artsuch as welding or adhesion. In one arrangement, the peelable layer 111is a label with a pressure sensitive adhesive. In some arrangements, thepressure sensitive adhesive is selectively registered on desired areasof the label such that certain areas of the label are free from thepressure sensitive adhesive.

The peelable layer 111 preferably comprises an aluminum layer providinga high barrier to moisture and gases to the compartments of the packageuntil it is being peeled off. In some arrangements, the peelable layeris part of the multi-layer material composition of the web that makesthe second wall 18″. In some arrangements, a scored or die-cut patterndefines the area of the peelable layer 111 that will be removed. In somearrangements, a section of the first wall 18′ and the second wall 18″ isscored or die-cut, providing a tab or a break-off tab that facilitatesthe removal of the peelable layer 111. The cartridge 110 may be readilyattached to an injector, a drug delivery device, a reservoir of these orother systems, or it may comprise a closure that is removed prior touse. The peelable layer 111 may include printed (or otherwise marked)information and may be attached to a person, a device, the drug deliverydevice receiving the content of the cartridge 110 (such as a syringe),or a document after it has been peeled off from the cartridge 110, andused as a label presenting that information.

It is understood that other labels may be attached to the cartridgearrangements according to this disclosure. These other labels mayinclude printed or otherwise marked information, machine readableinformation such as barcode or RFID circuit, and may be non-peelable orpeelable, and further attached to other objects such as a person, adevice, or a document. In some arrangements, an information-containingportion of the cartridge may be tearable or otherwise detachable fromthe rest of the cartridge in order to include or present thisinformation elsewhere such as on a document, attached to a patient, orto a device.

FIG. 12 shows an arrangement wherein the fitment (i.e. dispensing port)is attached to the external side of the second wall 18″ via a flange121. The flange comprises a conduit (not shown) aligned with an openingin the second wall 18″ (not shown) which communicates the content of thepackage with the dispensing port. The fitment or port 12 is attached tothe second wall 18″ by one of the means known in the art such as heatwelding or adhesion. The cartridge 120 may be readily attached to aninjector, a drug delivery device, a reservoir of these or other systems,or may comprise a closure that is removed prior to use.

FIG. 13 shows an arrangement wherein the cartridge 133 is associatedwith a manifold 134 disposed between a syringe 131 and a needle (shownhere covered by a needle shield 132). The manifold comprises a valvearrangement which, after the cartridge 133 has been activated, draws thecontent of the cartridge 133 into the syringe 131 when the syringe'spiston is retracted and delivers the content of the syringe 131 to theneedle when the piston is forwarded. In some arrangements, amanipulation of the manifold will cause disengagement of the cartridgefrom the manifold 134 when shifting from a dose drawing configuration toa dose injection configuration. U.S. Pat. No. 7,879,018 teaches a numberof manifold arrangements for accomplishing the same and is incorporatedherein in its entirety by this reference.

FIG. 13 illustrates the cartridge 133 joined to a 3-way coupler 134disposed between a syringe 131 and administration device 132. In thisarrangement, mixed constituents are transferred from the cartridge 133to the syringe barrel 131 just prior to injection by retracting thesyringe piston 135. The arrangement of FIG. 13 includes a pre-filledsyringe wherein the piston is in an inward position prior to use, whichallows for superior packaging density relative to regular prefilledsyringes wherein the piston is in a retracted position during storage.The piston is advanced inwardly to dispense the dispensable productthrough the administration device 132.

A valve system may be disposed in the coupler 134 to restrict the flowfrom the cartridge 133 to the syringe's barrel (i.e. reservoir), andfrom the reservoir to the administration device. The valve system mayinclude check valves that automatically control the flow with no needfor operator intervention. In one arrangement, the cartridge is movedrelative to the coupler to operate the valve system. This movement maybe inward or outward linear motion, rotation, or a combination of those.In one arrangement, certain movement of the cartridge relative to thecoupler disconnects at least a portion of the cartridge from thecoupler. This disconnect may be advantageous after transferring the doseto the reservoir of the syringe to “clean” the syringe configuration forinjection. The administration device 132 may include a needle, and aneedle safety feature and a syringe disabling feature may beincorporated with this arrangement. The needle may be configured as aninjection needle.

US Pat. Publication No. 2009/0221962 teaches a retractable syringe andplunger. The syringe has a barrel, a retractable needle mount to whichis mounted or is mountable a needle, and a plunger. The plunger includesan initially compressed spring, a means for engaging the retractableneedle mount, an integrally formed plunger seal, and a removablecontrolling means for facilitating control of the rate of retraction ofthe needle mount when engaged with the plunger. The needle mount is heldin the barrel by a holding means that prevents inadvertent retraction ofthe needle mount when the plunger is withdrawn to fill the syringe. Theholding means comprises a plurality of clips that may be integrallyformed with the barrel or may be present on a cap mounted to the barrel.An ejector means is also provided, wherein plunger depression can urgethe ejector means to release the needle from the holding means andthereby allow retraction of the needle mount following decompression ofthe spring. In one arrangement of the present disclosure, the cartridgeis associated with a syringe with a retractable needle mount such as theone taught by US Pat. Publication No. 2009/0221962. The pre-filledsyringe may be configured to operate by at least one of an autoinjector, a syringe pump, a controlled actuator, a mechanical ram orpressure.

FIG. 14 shows a cartridge 133 comprising a valved port 141 connectedwith a syringe 131. For the step of loading the syringe barrel with thedispensable product from the cartridge 133, the Luer cap 142 ismaintained in place. After merging the compartments of the cartridge 133and popping the closure between the merged compartment and thedispensing or valved port 141, the valved port 141 provides that whenthe syringe's piston 135 is retracted, the dispensable product will flowfrom the cartridge 133 to the syringe barrel (i.e. reservoir). When thepiston is advanced, the dispensable product is urged from the reservoirto the syringe tip and will not return to the cartridge 133. In onearrangement, the valved port comprises a check valve allowing fluid toflow out of the cartridge 133 and prevent reversed flow into thecartridge 133. In one arrangement, the valved port is manually operated,for instance, by rotation, axial movement, or a combination of these, toswitch between an open state and a closed state.

In one aspect of this arrangement, there is a cartridge for use with abeneficial agent delivery device having a fillable reservoir. Thecartridge includes a package that includes at least a first compartmentcontaining at least one constituent of a beneficial agent, a fitmentdisposed on the package, and a coupler joined to the delivery device forinterfacing the fitment in fluid communication with the fillablereservoir. The fitment being disposed on the package may include areleasable connection, a permanent connection, a connection thatprovides flow communication, or various other mountings and connections.

The coupler includes at least one closure interrupting the fluidcommunication until opened. The coupler is aseptically sealed. Thecoupler is configured to communicate with an administration device.Various closures are possible. For example, the closure may comprise amembrane, a stopper, a valve, or other structure that provides a seal.The closure may be reusable and operate between open and closedpositions. The closure may open when pierced or ruptured using a sharpobject (e.g., needle) or using pressure. The coupler includes a valvecontrolling the flow into and out of the package, wherein the valve isoperative by a relative motion between said coupler and at least one ofsaid fitment and said delivery device. In some arrangements, at least aportion of the cartridge is detachable from the coupler. In somearrangements, at least a portion of the cartridge is detachable from thecoupler after the reservoir has been at least partially filled with thebeneficial agent.

The delivery device may be selected from a group consisting of a medicalsyringe, staked needle syringe, safety syringe, retractable needlesyringe, auto-disabling syringe, auto-injector syringe, jet-injectorsyringe, intradermal syringe, subcutaneous syringe, intramuscularsyringe, infusor, infusion pump, sustained release delivery system, andpatch pump. The coupler may include at least a portion of a syringebarrel. The coupler and fitment may be joined by at least one of apress-fit, a glued-fit, a thermal weld, and a bonding.

In some arrangements, the cartridge is removable either during manualoperation or post manual operation. U.S. Pat. No. 7,879,018 teaches anumber of manifold arrangements for accomplishing the same and isincorporated herein in its entirety by this reference. In somearrangements, the syringe 131 is valved such that no flow is allowedthrough the syringe's tip when the syringe's piston is retracted, andflow is allowed to flow out of the syringe's barrel when the piston isadvanced. In some arrangements, the syringe's valve is a check valve. Insome arrangements, the syringe's valve is manually operated. In somearrangements, the syringe's valve and the cartridge's valved port 141are mechanically linked such that operating the cartridge valved port141 to shut off operates the syringe's valve to open, or vice versa. Thearrangement of FIG. 14 may be particularly advantageous wherein thedispensing tip has a construction that cannot accept a cartridge, forinstance, where the dispensing tip incorporates a staked needle, aretractable needle, a needle stick prevention device, or other safetydevices or mechanisms.

US Pat. Publication No. 2011/0015572 teaches a retractable syringe,plunger and releasable needle retaining assembly. The retractablesyringe typically has a glass barrel and is pre-filled with fluidcontents before use. The releasable needle retaining system comprises aretractable needle, a needle seal, a retaining member and an ejectormember that is operable to release the retractable needle from theretaining member. The retaining member has a mating surface for mountingto a complementary mating surface of an interior wall of a syringebarrel. The plunger comprises a plunger outer, a plunger rod frangiblyconnected to a controlling member, a spring, and a unitary plunger sealcapable of engaging the retractable needle. The plunger rod, plungerouter and the controlling member co-operate to releasably maintain thespring in an initially compressed state. After delivery of fluidcontents of the syringe, the plunger forces the ejector member torelease the retractable needle from the retaining member. Decompressionof the spring at the end of depression of the plunger facilitatesretraction of the retractable needle when engaged with the unitaryplunger seal. Dual locking systems prevent re-use of the syringe afterneedle retraction. In one arrangement of the present disclosure, thecartridge 133 is associated with the barrel of a safety syringe such asthe one disclosed in US Pat. Publication No. 2011/0015572, via a valvedport 141 arrangement of FIG. 14 .

Referring now to FIG. 15 , in some arrangements it is desired tolyophilize (freeze dry) a substance directly in the first compartment15. The first wall 18′ is pre-formed and welded to the flat, second wall18″. The first compartment 15 has an open end 151 and is longer than thefinal, sealed dimensions of this compartment. The first compartment 15is filled with a liquid substance. The cartridge is then placed in afreeze drier until the lyophilization process is completed, leaving adry cake at the bottom of the first compartment 15. The compartment isthen sealed to aseptically contain the lyophilized dose. The secondcompartment 16 may be filled and sealed prior to the lyophilizationprocess or after it. The second compartment 16 may be hermeticallysealed empty and then filled via fill wells 152 (see filling arrangementdescribed with reference to FIGS. 20 a-g ).

The arrangement of FIG. 15 is also advantageous for filling a product orconstituents thereof in a vertical position as shown in this figure.This arrangement may be particularly advantageous where there is a needfor a filling device to reach into compartment 15 via opening 151. It isalso advantageous where a product needs to flow or be dropped intocompartment 15 with gravity. In some arrangements, the secondcompartment 16 is filled prior to filling the first compartment 15. Insome arrangements, the second compartment 16 is filled after filling thefirst compartment 15. In other arrangements, the second compartment 16is filled simultaneously with filling the first compartment 15.

Referring to FIG. 16 , a further arrangement of a cartridge 160 is showncomprising a first compartment 15 holding a first substance orconstituent of a dispensable product, and a second compartment 16holding a second substance or constituent of a dispensable product. Thecompartments are separated by a first frangible seal 19′ that isrupturable to allow the first substance and the second substance tomerge. The second compartment 16 is separated from a female Luer lockfitment 12 by a second frangible seal 19″ that is rupturable to allowfluid communication between the cartridge and a dispensing device, suchas a syringe or an injector. The fitment 12 comprises a fluid passageway161, and a static mixer 162 disposed in the fluid passageway 161. Thearrangement is such that when the merged first substance and secondsubstance are transferred from cartridge 160 to a dispensing device thestatic mixer enhances the mixing of these substances to form a morehomogeneous product. An example of a static mixer is taught in U.S. Pat.No. 4,538,920, which is incorporated herein in its entirety by thisreference. The mixture may further be transferred back and forth betweenthe delivery device and the cartridge to repeat the mixing action at thestatic mixer. In some arrangements, the static mixer is constructed as apattern of passageways formed between the walls of the flexible packageby welding and pre-forming designated areas of the walls. The staticmixer may be merely a narrow nozzle, or a porous component accommodatedin the flow passageway between the cartridge and the delivery device.

FIG. 17 illustrates an arrangement in which the cartridge 170 comprisesa compartment 171 containing a first substance or at least oneconstituent of a dispensable product, and separated from a female Luerlock fitment 12 by a second frangible seal 19″. The fitment comprises afluid passageway 161 and a static mixer 162 disposed in the fluidpassageway 161. A syringe 173 containing in its reservoir a secondsubstance or at least one constituent of a dispensable product 174 isattached to the cartridge 170. The second frangible seal 19″ isrupturable to allow the first substance and the second substance tomerge. By drawing the syringe piston, the first substance is drawn outof the compartment 171 and into the syringe where the first substancemerges with the second substance. The syringe piston may be operatedback and forth to transfer at least a portion of the mixture to and fromthe cartridge 170 and create a more homogenous mixture as the materialflows through the static mixer 162. In one arrangement, the compartment171 is sufficiently expandable to receive substantially all of themerged substance of the cartridge and the syringe reservoir. In somearrangements, the cartridge 170 may comprise more than one compartmentthat may be merged with the first compartment 171 before or aftermerging the first compartment with the syringe. It will be obvious toone skilled in the art that a static mixer may be implemented in any ofthe previous arrangements of this disclosure in similar arrangements tothat of FIG. 16 or FIG. 17 . In particular, referring back to FIGS. 3and 4 , the static mixer may be disposed in the syringe's stem orplunger.

FIG. 18 shows another arrangement of a cartridge 180, comprising a firstcompartment 15 containing a first substance or at least one constituentof a dispensable product, a second compartment 16 containing a secondsubstance or at least one constituent of a dispensable product, and astatic mixer 184 disposed there between, separated from the firstcompartment 15 by a frangible seal 181, and separated from the secondcompartment 16 by a frangible seal 182. At the point that the firstsubstance and the second substance are to be mixed, the first frangibleseal 181 and the second frangible seal 182 are ruptured such that theupper wall 183 is rearranged as indicated by dashed line 183′ to allowthe first substance and the second substance to communicate via thestatic mixer 184. The first compartment 15 and the second compartment 16are not fully inflated as the first recessed area 185 of the firstcompartment 15, and the recessed area 186 of the second compartment canexpand to receive substance from the other compartment. Consequently, agood mixture of the first substance and the second substance may beachieved by alternately compressing the first compartment 15 and thesecond compartment 16, and transferring the mixture of the first andsecond substances through the static mixer 184. The static mixer 184 isshown here as a porous body, and alternatively be another static mixerknown in the art.

A third frangible seal 19″ is rupturable to establish communicationbetween the mixture and the fitment 12. The arrangement further comprisea backing 187 supporting the cartridge 180, and a rocker comprising afirst compression panel 188′ and a second compression panel 188″. Therocker may be movable to rotate relative to the backing 187 toalternately depress the first compartment 15 with the first compressionpanel 188′ and the second compartment 16 with compression panel 188″ inthe direction 189. The rocker and backing arrangement facilitate anefficient operation of the mixture process by more efficiently andsystematically compressing the first and second compartments 15 and 16and transferring the content across the static mixer 184. At the pointthat the mixture is ready to transfer to a dispensing device through thefitment 12, the first compression panel 188′ may be resting where thefirst compartment 15 is depleted so that substantially all of themixture is expressed from the second compartment 16 to the fitment 12.The rocker may be associated with the backing 187 via a hinge or aliving hinge, and it may be operated manually or by a device.

FIG. 19 shows another arrangement of a cartridge 190 comprising a firstcompartment 15, containing a first substance, a second compartment 16containing a second substance, and an array of pre-formed intercrossingchannels 191 positioned therebetween to provide a static mixer thatenhances the mixing of the first and second substances as they aretransported back and forth between the first compartment 15 and thesecond compartment 16.

Referring now to FIGS. 20 a to 20 g , one possible manufacturing methodof the cartridge is described. In one arrangement, this manufacturingprocess is accomplished on a form-fill-seal system.

FIG. 20 a shows a pre-formed flexible first wall 18′ of a package forstoring constituents of a beneficial agent. The package includes a firstcavity 15 (subsequently the first compartment) for receiving a firstconstituent, a second cavity 16 (subsequently the second compartment)for receiving a second constituent, a first uninterrupted area with thesurface at the peripheral edge of cavity (subsequently the firstfrangible seal area) positioned there between, a fitment cavity forreceiving a fitment, and a second uninterrupted area with the surface atthe peripheral edge of compartment (subsequently the second frangibleseal area) between the second compartment 16 and the fitment cavity 203.The second cavity 16 may receive a non-fluidic material or a poorlyflowing material such as, for example, powder, compressed oragglomerated powder, granules, pellets, solid, tablet, capsule, slurry,paste, high viscous fluid, emulsion, and a combination of the above. Thesecond substance is filled into the second cavity 16 by an appropriatefilling system that provides the type of material that needs to befilled. The second compartment 16 may also be filled with water or otherlow viscosity fluids. It may be challenging to completely fill thesecond compartment 16 with water or aqueous solution due to surfacetension and other properties of the fluid, which may make it challengingto keep the fluid in the cavity as it is being sealed.

Another challenge is that liquid filling is a relatively slowmanufacturing process for a number of factors, one of which is avoidingfoaming or bubble formation as the liquid is filling the secondcompartment 16. In one arrangement, this challenge is addressed byfreezing aliquots of fluid in a mold preferably having the secondcompartment 16 shape, then transporting the solid aliquots into thecavity by one of the means known in the art. The production line, and inparticular the filling station, may be designed such that heat transferto the frozen liquid aliquots is limited so that the frozen liquidaliquots stay substantially solid until the second compartment 16 issealed. Thereafter, the frozen liquid aliquots may be thawed. Heattransfer to the frozen liquid aliquots during the filling process may belimited by controlling the temperature throughout this processsubstantially low, and by using machine construction and selectingcontact material to the package that provide appropriate heat transferproperties. The frozen liquid aliquot may be inspected for weight andother controlled properties and parameters prior to introduction to thesecond cavity 16.

In one arrangement, more than one frozen liquid aliquot is filled to thesecond compartment 16, which may have the same, similar or differentcompositions. These aliquots may have complementary shape that mayjointly form substantially the shape of the second compartment 16. Inone arrangement, the aliquot is frozen directly in the secondcompartment 16 or on the reciprocal flat second wall 18″ (not shown) ofthe package. In another arrangement, the second substance is a loosepowder or another form of dispersible dry substance which may bechallenging for filling to the second compartment 16. Loose powderfilling may also be a limiting factor of the manufacturing speed and achallenge for proper inspection of the aliquot fill dose. In onearrangement, in order to facilitate the powder filling (or similar drysubstance), the powder is slightly compressed to form a looselyaggregated tablet, or a unitary body, and is filled in that form intothe compartment of the package by one of the tablet filling means knownin the art. The unitary body may be molded to substantially the sameshape as the shape of the second compartment 16. A dedicated formulationmay be required to achieve the level of aggregation at a givencompression rate. The tablet may be inspected prior or during the fillprocess of the second compartment 16.

In one arrangement, after the tablet has been sealed in the secondcompartment 16, the compartment is externally manipulated tode-agglomerate the tablet, thus improving the substance solubility (ordispersibility) at the time of mixing with a dilutant. The externalmanipulation may include directing energy to the unitary body throughthe wall of the package via at least one of, but not limited to,compression of the compartment, vibration including ultrasonicvibration, radio frequency vibration, acoustic vibration, applyingmechanical impact to the compartment, and exposure to high or lowtemperatures. In one arrangement, the unitary body is formed directly inthe second compartment 16 or on the reciprocal flat second wall 18″ (notshown) of the package. The first compartment 15 provides anotherarrangement for efficiently filling a low viscosity fluid tosubstantially fill the first compartment 15. A first filling compartmentor chamber 201′ and a second filling compartment or chamber 201″ arepre-formed in the first wall 18′. The first filling compartment orchamber 201′ may also be referred to as an inlet filling compartment inthis embodiment. The second filling compartment or chamber 201″ may bereferred to as an outlet filling compartment in this embodiment, and maybe referred to as an evacuation compartment in some embodiments.

The first passageway 202′ and second passageway 202″ are arranged andconfigured to connect the first and second filling compartments 201′,201″ in communication with the first compartment 15. The firstpassageway 202′ may be referred to as an inlet passageway, a firstfilling channel, or a first pre-formed filling channel. The secondpassageway 202″ may be referred to as an outlet passageway, a secondfilling channel, or a second pre-formed filling channel. The first andsecond passageways 202′, 202″ may be referred to as fillable channels orpassageways used to fill the first and second sealed compartments 15,16. FIG. 20 a shows a portion of a web formed to include the details ofone cartridge. It would be understood to those skilled in the art thatin a normal manufacturing practice an array of details for multiplecartridges may be formed on a larger spread of the first wall 18′, andmay be handled simultaneously at subsequent forming and filling steps.The cartridge 200 or any portion thereof (e.g., the first wall 18′) maycomprise a blister package that defines pre-formed cavities such as thefirst and second sealed compartments 15, 16. The first wall 18′ may bepre-formed from a flat web by one or more of the processes including,for example, thermoforming, cold forming, vacuum forming, pressureforming, plug-assist forming, or pre-forming from non-web raw materialsuch as by injection molding, blow molding, injection-blow molding,blow-fill-seal, blow-fill-insert-seal, or other methods known in theart.

FIG. 20 b shows a subsequent step of the manufacturing process of thecartridge 200. After the second compartment 16 (in this Figure at theopposite side of the cartridge 200) has been filled, the secondcompartment 16 is hermetically sealed with a lid web or second wall 18″.The second wall 18″ is sealed to the entire uninterrupted surface of thefirst wall 18′. In one arrangement, the inner layer of the first wall18′ and/or the second wall 18″ comprises an adhesive with controllablepeeling (adhesion) force, where a lower sealing temperature (forinstance about 300° F.) results in a peelable adhesion (“frangibleseal”), and a higher sealing temperature (for instance about 420° F.)results in a permanent non-peelable adhesion. In one arrangement, thefrangible seal peeling force is about 1,000 g/in{circumflex over ( )}2,and the permanent seal is greater than about 1,600 g.in{circumflex over( )}2). In one arrangement, at the first sealing step shown in FIG. 20 b, substantially all of the uninterrupted surface of first wall 18′ isadhered to the second wall 18″ to form a frangible seal that extendscompletely around a circumference of the second compartment 16, andextends around substantially an entire circumference of the firstcompartment 15 with the exception of the first and second passageways202′, 202″, which remains unsealed to allow fluid communication betweenthe filling compartments and the first compartment 15. With the secondwall 18″ now attached to the first wall 18′, a filling compartment andexhausting compartments are now formed that communicate with the firstcompartment 15 via channels or passageways formed between the two webs.A pattern 401 of the frangible seal is shown in FIG. 20 f.

The first filling hole (i.e. first filling port) 204′ and the secondfilling hole (i.e. second filling port) may be made in the second wall18″ in advance of this manufacturing step by one of the means known inthe art such as, for example, punching, die-cutting, and laser cutting.In some arrangements, the second wall 18″ is joined with the first wall18′ prior to piercing the filling ports, and first and second walls 18′,18″ are pierced by the filling device at the filling step. In onearrangement, the first compartment is filled with a first substancethrough the first filling hole 204′ while the second filling hole 204″allows for evacuation of gases from the first compartment 15 duringfilling. A filling source may be associated with at least one of thefilling holes 204′ and 204″ during the filling process to facilitate theintroduction of a substance to the first compartment, and drawing thegases through the exhaust compartment. At least one of the secondfilling hole 204″ and second passageway 202″ may be sized to prevent thesubstance from reaching the exhaust port. In one arrangement, thefilling device comprises a needle or a tube that is bent to reach intothe first filling channel 202′. The gases drawn through the first orsecond compartment 15, 16 and one of the filling holes 204′, 204″ may beconnected to an exhaust line (not shown) that draws the gases away fromthe cartridge. The compartment through which gas is evacuated may bereferred to as a gas evacuation compartment.

In one arrangement, the filling device comprises a cylindrical fillingtube with a diameter greater than that of the filling hole 204′ suchthat it tightly fits and fluid-tight seals when introduced to thefilling hole 204′. In one arrangement, the filling holes 204′ and 204″are formed during the filling step by a sharp filling object (such as ahollow needle or other piercing element) that pierces through the secondwall 18″, into filling compartments 201′ and 201″ in a fluid-tightfashion. The sharp filling object may be a tube (e.g., a capillary tube)that is connected in fluid communication with a first constituent. Thesecond wall 18″ (also referred to as a web) may form a fluid-tight sealwith the tube.

This last arrangement is particularly beneficial as the package ishermetically sealed prior to the introduction of the constituent, whichcan be performed on a different portion of the filling line or on adifferent line of a filling machine (e.g., a form-fill-seal line). Thepackages may be stacked between the sealing step and the filling step.In one arrangement, a rubber or semi-rigid sealing member is disposed inat least one of the filling compartments 201′ and 201″ forming aninterface to the filling source to facilitate the sealing of the fillingcouplers to the cartridge. In one arrangement, the channels' crosssection is sufficiently small to prevent the filled substance fromspilling out of the first compartment 15, due to surface tension orparticles size of the substance.

In one arrangement, a check-valve is disposed in at least one of thefirst and second filling compartments 201′ and 201″ to control the flowof a substance into the first compartment 15. A semi-permeable objectmay be disposed in one of the filling compartments 201′, 201″ and thefirst and second passageways 202′, 202″ to allow gases to escape duringfilling and prevent the substance from leaving the first compartment 15by backflow. In one arrangement, the flow evacuating the firstcompartment 15 during filling is monitored and filling is discontinuedwhen the evacuating fluid switches from gas to the filled substance. Asensor may be positioned in one of the first and second passageways202′, 202″ for detecting presence of a substance. The sensor mayindicate that the filling compartment is filled. The sensor may compriseelectrodes disposed on the second wall or in between layers of thesecond wall 18″ material. The electrodes and the associated sensingcircuit may be configured to sense conductivity of the fluid in thesecond passageway 202″.

The first filling channel 204′ is configured to direct the substanceentering the first compartment to glide on the second wall 18″ and thuspreventing jetting that may result in undesired bubbles or foaming ofthe filled dose. A dedicated flow deflector may be disposed in the firstand second passageways 202′, 202″ or one of the filling compartments201′, 201″ to facilitate the gliding of the filled substance on the wallof the first compartment 15. In one arrangement the package 200 ismolded to the configuration of FIG. 20 b for example by blow-molding orgas assist molding.

FIG. 20 c shows a subsequent manufacturing step of the cartridge 200. Ina second welding step, the first and second passageways 202′, 202″ aredepressed and welded to completely seal the first substance in the firstcompartment 15. The sealing temperature may be higher than the frangibleseal welding temperature to avoid rupture of the first and secondpassageways 202′, 202″. In one arrangement, this sealing step is furtherapplied to the circumference of the cartridge 200 to apply permanentseal properties to at least some of the areas that were earlier sealedas a frangible seal. A sealable insert may be disposed in the channelsto facilitate welding and sealing of the channels. This insert may bemade of a material with substantially low melting temperature that isadherable to the inner surface of the first and the second walls 18′ and18″ to enhance the seal of the first and second passageways 202′, 202″at the second sealing step. An insert may be disposed in at least one ofthe first and the second filling channels and the first and the secondfilling compartments to provide at least a portion of a flow controldevice. The flow control device may be one of, for example, a valve(e.g., an isolation valve or a check valve), a flow or pressureregulator, a flow or pressure restrictor, or a flow deflector, etc. Apattern 402 of the permanent seal is shown in FIG. 20 g . The permanentseal pattern 402 is shown in FIG. 20 g partially overlapping thefrangible seal pattern 401.

Referring now to FIG. 20 d , the cartridge is trimmed from the webmargins by one of the means known in the art such as, for example,punching, ruler steel cutting, laser cutting, etc. FIG. 20 e showscartridge 209 without the fitment cavity 203 and fitment 12.

It would be understood to those skilled in the art that the order ofmanufacturing steps disclosed above may be rearranged in whole or inpart to best suit a particular design, application, and applicablemanufacturing equipment. It would also be understood to those skilled inthe art that additional manufacturing steps may be performed prior to,in between, and after the steps described in FIGS. 20 a to 20 d.

The fitment 12 is welded to and positioned between the first pre-formedwall 18′ and the second wall 18″ prior to or during the frangible sealwelding step, prior to or during the permanent seal welding step, or ina subsequent step by one of the fitment welding means known in the artincluding, for example, heat stake welding, impulse welding, vibration,ultrasonic, RF welding, and light beam welding.

FIG. 20 f illustrates a first welding step of the first pre-formed wall18′ to the second flat wall 18″ of the package of the cartridge 200. Thesealing pattern 401 completely circumscribes the second compartment,hermetically sealing the content of the second compartment. The firstcompartment 15, the filling compartments and the filling passageways aresealed around leaving the passageways between the filling compartmentsand the first compartment open. The subsequent location of the fillingports is marked (204′) and (204″) and they will be opened at a latermanufacturing step, hence the frangible seal 401 hermetically seals thecavity comprising the first compartment 15 and the filling compartments.

FIG. 20 g illustrates the cartridge 200 after the permanent seal step.The permanent seal pattern 402 surrounds the first and the secondcompartments overlapping most of the frangible seal pattern except forthe first frangible seal section 19′ and the second frangible sealsection 19″. In an earlier step, the filling ports 204′ and 204″ werepierced by the filling device and the first compartment was filled asdescribed earlier. The filling channels are sealed by the permanent sealpattern 402 hermetically resealing the first compartment.

FIG. 21 a shows an exploded view of a syringe 210 comprising a staticmixer for mixing substances. In one arrangement, a first substance iscontained in the syringe 210 and a second substance is transferred froma cartridge (not shown) to the syringe, where it is mixed with the firstsubstance. In another arrangement, at least a first substance and asecond substance are transferred to the syringe from one or morecartridges (or from a different source of the substance), separately orpre-mixed, where a mixture process is applied to the substances ormixtures. In some arrangements, a cartridge is associated with thesyringe 210 in a similar fashion to that of the arrangements of FIG. 2,3, 4, 13 or 14 . A plunger 214 is movably disposed in the syringe barrel212 in a fluid-tight fashion. A piston 213 is concentrically disposed ina movable fashion in the annular bore of the plunger 214 in afluid-tight fashion, and the piston further comprises a static mixingplate 217 (or static mixer) that extends laterally from the distal endof the piston 213. A local axial groove 215 in the annular bore of theplunger 214 is made to receive laterally protruding detent tooth 216 ofthe piston 213.

FIG. 21 b shows a section view of the mixing syringe 210 containing afirst substance 218. FIG. 21 c shows a section view of the mixingsyringe 210 where the piston is retracted toward the proximal end of thebarrel 212. The static mixer pushes the plunger along with the piston,thereby allowing a second substance to enter the barrel 212 to formmixture 218′. The source of the second substance is not shown. However,as described above, the source may be a cartridge associated with thesyringe 210 in one of the arrangements provided in this disclosure. Itis understood that if the second substance is not entering the syringe210 from the Luer tip, the Luer tip is sealed with a cap, a closure, avalve or another means such that no flow from the tip occurs during thepiston retraction.

FIG. 21 d shows a mixing step where the piston 213 is moved back andforth, diverting the mixture 218′ to flow through the openings in thestatic mixer 217 and enhance the mixing of the mixture 218′ to form ahomogeneous product. The detent tooth 216 is aligned with the axialgroove 215 (not shown) such that the piston is freely movable relativeto the plunger 214. The plunger is free to glide along the barrel as itmoves into and out of the sealed volume between the barrel 212 and theplunger 214. In one arrangement, the piston is rotatable to furtherenhance the mixing. In one arrangement, the static mixing plate isreplaced with another static mixer known in the art such as a porousmaterial. In one arrangement, the piston is operated by a device such asa controlled electric actuator. The syringe tip and other ports to thesyringe are preferably tapped during the mixing process to avoidspillage of mixture 218′ or introduction of materials into the barrel212.

FIG. 21 e shows the syringe 210 as the piston is retracted, such thatthe detent tooth 216 enters axial groove 215 (not shown). The piston isrotated such that the detent tooth 216 engages with the radial groove219 of the plunger 214, at which position the plunger 214 and the piston213 are firmly engaged and are movable as one. In one arrangement, thebarrel and plunger comprise a non axi-symmetric cylindrical profile toprevent the rotation of the plunger due to the piston 213 rotation. Inone arrangement, the plunger 214 comprises a rigid core to facilitateengagement with the piston 213. As the syringe's 210 tip is untapped,the mixture 218′ is dispensed by advancing the piston 213 and plunger214 toward the distal end of the syringe 210.

FIG. 22 a and the partial cross-section in FIG. 22 b illustrate acartridge associated with a staked needle syringe. The cartridge 10comprises a first substance compartment 15 and a second compartment 16separated by a rupturable barrier or first frangible seal 19′. Thecartridge 10 further comprises a fitment 222, for communicating thecontent of the cartridge 10 with a staked needle syringe 221. Theproximal end 224 of the fitment 222 is sealed between the first wall 18′and the second wall 18″ of the cartridge 10, and is separated from thesecond compartment 16 by a rupturable barrier or second frangible seal19″ that is formed by directly sealing the first wall 18′ and the secondwall 18″. The distal end 223 of the fitment 222 is made to removablyreceive the tip of the syringe 221 in a fluid-tight fashion, and theproximal end 224 of the fitment 222 is made to receive the tip of aneedle 225 and protect the tip. A passageway 226 in the fitment 222communicates between the needle and the content of the cartridge 10. Thecartridge 10 provides an aseptic needle protector to the needle 225. Theneedle 225 may be an injection needle.

In one arrangement, the original needle protector (not shown) is removedfrom the syringe and is replaced by cartridge 10. The content of thecartridge 10 is transferred to the syringe 221 after the secondfrangible seal 19″ has been ruptured. In some arrangements, thecartridge 10 is mounted on the syringe during the manufacturing process.In one arrangement, the cartridge 10 has only a single compartment. Inone arrangement, the cartridge has at least two compartments that aremerged prior to transferring the content of the cartridge 10 to thesyringe 221. In one arrangement, the syringe 221 comprises a safetymechanism which, at the end of the injection, retracts at least aportion of the needle 225 to a position that protects from needlesticks. In one arrangement, the syringe 221 comprises a needle stickprevention device that at least partially protects the needle tip afterthe injection of the content has been completed.

Typically, with pre-fillable syringes, the syringes are supplied to thefilling process disassembled, and the syringe is fully assembled afterthe content has been filled. The arrangement of FIGS. 22 a and 22 bprovides for an advantageous manufacturing method wherein (a) thesyringe 221 is supplied assembled and finished, (b) the cartridge 10 isfilled and sealed with the desired content, and (c) the cartridge 10 isassembled. This process may be completed in an aseptic environment orthe product may be terminally sterilized. Thus, the approach allows forproducing a pre-filled syringe assembly that does not require the actualsyringe components assembly. In addition, the cartridge may be markedand labeled with the content information without needing a specialsyringe label or package to provide this information. A label, or aportion of a label, of the cartridge 10 may be transferable to thesyringe to maintain the product identification after the cartridge 10has been removed.

FIGS. 22 a and 22 b illustrate a cartridge adopted to communicate with astaked needle syringe. The cartridge 10 comprises two mergeablesubstance compartments. However, the cartridge 10 may include merely onecompartment or more than two compartments. The connection between thesyringe 221 and the fitment 222 is shown as a fluid-tight slip-fit.However, other fitting features may be incorporated to facilitate atight connection between the syringe 221 and the cartridge 10, theirassembly, or their dismantle, including, for example, a thread, ahelical ramp, a Luer fit, a Luer-lock fit, an O-ring, a rubber sealcomponent, an interlocking feature, a snap feature, other features knownin the art to facilitate a fluid-tight, removable connection, or acombination of the above. The distal end 223 of the fitment 222 maytightly fit around the needle 225, providing a fluid-tight seal aroundthe distal end of the needle that prevents the content of the cartridge10 from reaching to the space between the proximal end of the fitment222 and the proximal end of the needle 225, and prevents air fromreaching into the needle from that area. The fitment may be at leastpartially made from elastic material. The fitment 222 may be designed toaccommodate the cartridge 10 in different orientations relative to thesyringe. In one arrangement, the cartridge 10 and the syringe 221 may atleast partially overlap or rest side-by-side. The syringe's piston andbarrel may be sealed at their proximal end by an aseptic membrane 229such that the content contact surfaces will remain sterile withoutneeding a sterile overwrap until the time of use. In one arrangement,the staked needle syringe is replaced with a retractable needle syringesuch as the syringe taught by U.S. Pat. No. 8,052,654, which isincorporated herein in its entirety by this reference.

Referring to FIG. 23 a and its scaled-up partial section view in FIG. 23b , another preferred arrangement of a cartridge and a staked needlesyringe is illustrated. A coupler 237 is axially disposed around theneedle 225 and is removably joined to the tip of the syringe 221 in afluid-tight fashion. The coupler 237 protects the needle from physicaldamage and the operator and subject from accidental needle sticks. Thecoupler 237 may be configured as a needle stick preventing device or areuse preventing device. The coupler 237 may be referred to as analignment glider. The coupler 237 may provide a seal with at least oneof the syringe 221 and a fitment 232 of the cartridge 10.

The distal end of the needle 225 is further supported by a centeringpiece 238 (e.g., centering glider), coaxially, movably disposed in theadapter 237 and around the needle 225. The fitment 232 of the cartridge10 comprises a proximal section 234 attached to the cartridge walls, anda distal end 233 having an elongated cylindrical construction that canbe axially inserted into the coupler 237. With this arrangement, theneedle 225 remains protected until the assembly with the cartridge 10.In one arrangement, at least one end of the coupler 237 positioneddistal from the syringe 221, or the distal end of the fitment 233, isaseptically sealed with a closure such as a thermally sealed foil, acap, or knock-off or twist-off members as illustrated in FIG. 23 g .This closure maintains the needle sterile until integration with thecartridge, wherein the coupler 237 is removed or ruptured. In onearrangement, the manufacturing method is such that the syringeassemblies 231 are supplied assembled and sterile to the integrationline with the cartridge 10.

FIG. 23 c and its scaled-up partial section view in FIG. 23 d illustratethe arrangement of FIGS. 23 a and 23 b when the syringe assembly 231 andthe cartridge assembly 10 are engaged. The distal end 233 of the fitment232 is inserted into the adapter 237, thereby pushing the centeringpiece 238 to expose a substantial portion of the distal end of theneedle that penetrates the fitment passageway 236 to establish fluidcommunication between the syringe 221 and the cartridge 10. Afluid-tight seal may be provided by a tight fit between the needle 225and the fitment 232. The fitment 232 may be at least partially made fromelastic material to enhance the seal with the needle 225. The fitment232 may further include a membrane sealing the distal end 233 orelsewhere along the passageway 236, thereby further enhancing the sealbetween the fitment 232 and the needle 225, as well as furthermaintaining the cleanliness of the passageway 236 until it is assembledwith a cartridge 10. In one arrangement, the distal end of the fitment233 forms a fluid-tight seal with the centering piece 238 and thecentering piece forms a fluid-tight seal with the coupler. Hence, fluidis prevented from reaching the area between the needle and the coupler.

The content of the cartridge 10 is drawn into the syringe 221.Alternatively to the seal between the needle 225 and the fitment 232, aseal can be established between (a) the centering piece 238 and theadapter 237, (b) the centering piece 238 and the needle 225, (c) thesyringe's 221 tip and the adapter 237, and (d) the fitment 232 and theadapter. In some arrangements, two or more substance compartments in thecartridge 10 are merged and allowed to mix before the content istransferred to the syringe 221. In some arrangements, substance in thesyringe 221 reservoir is transferred and merged with a substance in thecartridge 10 before drawing the merged product. For example, thecartridge 10 may contain a dry substance, and the syringe 221 maycontain a dilutant, the dilutant is transferred to the cartridge 10 andallows the powder to dissolve, and the merged product is eithertransferred back to the syringe, dispensed to a subject, or transferredto another device. In one arrangement, the syringe is pre-filled with asubstance, and the content of the cartridge 10 is transferred to thesyringe 221, allowing the content to merge with the substance in thesyringe 221. The integration of the syringe assembly and the cartridgemay be performed on a manufacturing line or manually by a person at alater stage before injection.

FIG. 23 e , and its scaled-up partial section view in FIG. 23 f ,illustrate the arrangement of FIGS. 23 c and 23 d when the cartridge 10is removed. The adapter 237 remains on the cartridge 10, and the needleis exposed as the syringe 221 is now ready for injection. In onearrangement, a mechanical interlock ensures that the adapter 237 remainswith the cartridge 10. Such mechanical engagement may include a thread,a helical ramp, a snap, a tight fit, or other engaging and disengagingfeatures known in the art. In one arrangement, the adapter 237 remainson the syringe 221 when the cartridge 10 is removed, to continueproviding protection to the needle 225, and the adapter 237 is removedprior to injection by the operator.

FIG. 24 illustrates another arrangement similar to the arrangement ofFIG. 23 with the exception that a rubber septum 241 is disposed on thetip of the needle, and a spring 242 biases the centering piece 220 andthe septum 241 toward the distal end of the adapter 237. The needle isaseptically sealed by the septum 241. For transferring material betweenthe cartridge 10 and the syringe 221, the distal end 233 of the fitment232 is introduced into the adapter 237, thereby displacing the septumand centering piece backward, and exposing the tip of the needle 225 tothe passageway 226 in the fitment 232. When the cartridge 10 is removed,the spring 242 causes the septum to return to cover the tip of theneedle 225, thereby providing protection from mechanical damage andcontamination to the needle 225 until the time of use. The adapter 237is removed with the spring 242, the centering piece 220, and the septum241 prior to use of the syringe 221. FIG. 24 b illustrates thearrangement of FIG. 24 a with the addition of an aseptic foil preventingcontamination to the needle and septum until integration with thecartridge.

FIG. 25 a illustrates a pre-filled cartridge comprising a coupler 250and a package 10 associated via the fitment 257. The coupler assemblycomprises a needle assembly 253 comprising a Luer lock hub 255 and astainless steel canula 254 joined to the hub 255. The needle assembly253 (or needle) is accommodated in a needle cap formed in the coupler251. The coupler further comprises a fluid passageway 258 forcommunicating the needle 253 with the cartridge 10. A rubber sheath 252disposed in the coupler 251 forms an aseptic seal between the needle hub255 and the coupler. The tip of the rubber sheath 252 forms afluid-tight closure of the fluid passageway 258, which is pierced by thecanula 254 to establish fluid communication between the needle 253 andthe package 10′. The Luer end 256 of the needle hub 255 is sealed with aremovable aseptic closure either in the form of a sealed foil, a closureor other means known in the art. The cartridge 10 comprises a firstrupturable barrier or frangible seal 19′ segregating between a firstcompartment containing a first constituent and a second compartment 16containing a second constituent. The first and second constituents areallowed to merge when the rupturable barrier is ruptured. In anotherconfiguration, the cartridge 10 comprises a single constituent of thebeneficial agent. In yet another embodiment, the cartridge comprises atleast a third compartment comprising a third constituent segregated fromthe second or the first compartments by a rupturable barrier. A secondrupturable barrier or frangible seal 19″ provides a closure between thesecond compartment 16 and the fitment 257 leading to the fluidpassageway 258 in the coupler 251.

FIG. 25 b illustrates the arrangement of FIG. 25 a after the first andthe second rupturable barriers have been opened, allowing the first andsecond constituents to merge, and establishing fluid communication ofthe mixture in joined compartment 16′ with the needle 253 via thecoupler 251. This arrangement provides a simple pre-filled cartridgethat can be mounted on a standard Luer syringe 259 via engagement of thefemale Luer connector of the needle 253 with the male Luer of the Luersyringe 259, to transfer a dispensable product or constituents of suchfrom the cartridge 10 to the reservoir of the syringe 259. The productin joined compartment 16′ can then be taken into the syringe byretracting the syringe's piston, after which the coupler may be removedto expose the needle 253 for injection as shown in FIG. 25 c . In oneconfiguration, the syringe may contain a third constituent that may bemerged with the product held in joined compartment 16′ either by drawingthe product in joined compartment 16′ into the already partly filledsyringe, or by first dispensing the third constituent from the syringeto the cartridge 10 and secondly draw the mixture back to the syringe orto a different delivery device. The coupler 251 further provides abacking for part of the cartridge 10.

FIG. 25 d shows the two subassemblies of the cartridge assembly 250including the package 10′ and coupler assembly 250′. FIG. 25 e shows anexploded view of the coupler assembly 250′ (also referred to as a cap).

The coupler 252 is a cap of the administration portion of a deliverydevice in a form of a needle assembly 253. The cap includes a firstcompartment 245 configured to receive a proximal end 247 of theadministration device, a second compartment 246 configured to receivethe distal portion 248 of the administration device, and a barrier 249forming a fluid-tight seal between the first and second compartments245, 246. The proximal end 244 of the first compartment 245 isconfigured to communicate with the administration portion 253. Thebarrier 249 is configured to tightly seal around a portion of theadministration device 253 between the proximal end and the distal end ofthe barrier 249 (i.e. around the canula 254).

FIG. 26 illustrates a pre-filled unit-dose aseptic reconstitutioncartridge comprising a cartridge or package 10 adapted to communicatewith a syringe 260. The syringe 260 comprises an intradermal (ID)injection adapter (ID Adapter), comprising a forwardly protruding skid264 facilitating a shallow insertion of the needle 262 into the skin. USPat. Publication Nos. 2010/0137831 and 2011/0224609 teach similararrangements for an adapter to facilitate intradermal injection and areincorporated herein in their entireties by this reference. The IDadapter may be an integral portion of the syringe 261 or be a clip-on tothe syringe 261, thereby forming an ID syringe. A recess 267 is formedin the skid 264 to facilitate the introduction of the fitment 265 of thecartridge 10 onto the needle hub 266 of the syringe 260.

FIG. 27 a illustrates the cartridge 10 mounted on an ID syringe wherethe cartridge 10 and syringe 260 are positioned in a linear arrangement.The view provides an orientation of the section view of FIG. 27 b . FIG.27 b illustrates the fitment 265 press-fitted on the needle hub 266forming an aseptic connection. A rubber stopper provides a closure topassageway 271 (also referred to as an inner bore) of cartridge 10 andis pierced by needle 262 to establish fluid communication between thesyringe and the cartridge 10.

FIG. 28 illustrates a similar arrangement to that of FIG. 10 with theexception that the fitment 281 is made such that the cartridge 10 ispositioned parallel to the syringe barrel instead of in line with thesyringe axis.

FIGS. 29 a and 29 b illustrates a cartridge configuration 290 comprisinga coupler 293 communicating an intradermal needle assembly 291 and thecartridge 10. The coupler accommodates a needle assembly comprising acanula 292 and a needle hub 291 comprising the forward protruding skidat its distal end and a Luer connector at its proximal end 297. Thecoupler 293 is used as an aseptic cap engaged with the needle hub 291 insealing area 299 maintaining the needle 292 and the skid area sterile.Hence, the coupler 293 may operate as a cap that covers, protects, or atleast partially encloses an administration portion such as the needle292. A Luer cap 298 is aseptically sealing the Luer connector at theproximal end 297 of the needle hub 291 to form an integrally sealedcartridge that remains sterile without the need of a sterile overwrap.The cartridge 10 and the coupler are connected via the fitment 296. Thefitment is preferably heat welded to the wall of the cartridge 10, andis connected to the coupler by one of the means known in the artincluding heat welding, bonding, or a tight mechanical fit. Therupturable seal 19 between the first compartment 15 and the secondcompartment 16 provides a closure segregating the compartments from thecoupler 293.

FIG. 29 b illustrates the arrangement of FIG. 29 a wherein the Luer cap298 is replaced with a Luer syringe 259, and the rupturable seal isopened to allow the constituents in the first and second compartments15, 16 to merge and establish fluid communication with the needle viapassageway 295, thereby allowing filling the reservoir of the syringe. Arubber closure or stopper 294 limits the dead space of the constituentsin the coupler to the minute volume of passageway 295, thus limitingwaste of the product 15′. FIG. 29 b shows the piston of the syringeretracting to receive the product 15′ in the syringe's barrel (i.e. thesyringe's reservoir). The coupler 293 is removed to expose the needleand the ID adapter for injection. The coupler 293 provides a backing tothe cartridge 10 thereby facilitating depression of the compartments ofthe cartridge 10.

FIG. 30 illustrates a cartridge arrangement 300 similar to the cartridgearrangement 290 of FIGS. 29 a and 29 b with the exception that the IDadapter 291 is a separate part from the needle hub 301, and is mountedon a needle hub. A sealing portion 302 of the needle hub 291 seals withthe coupler 293 at a sealing area 303.

FIG. 31 a shows a cartridge arrangement 310, mostly similar to thecartridge arrangement 300 of FIG. 30 with the exception that the needlehub 311 is movably disposed in the ID adapter 313, movable between aninjection position and safe-discard position. A latch mechanism 315retains the injection position at a sealing interface 314 with theneedle hub 311. A spring may be disposed in area 312 to bias the IDadapter or needle hub 313 to the safe-discard position. FIG. 31 billustrates cartridge arrangement 310 when the latch has been operatedto release the needle hub. The needle assembly is retracted to bring theneedle tip to a confined section 316 to reduce the risk of needlesticks. In one arrangement, the needle hub is permanently locked in thisposition to prevent repeated use of the needle.

FIG. 32 shows a cartridge arrangement 320 similar to arrangement 290 ofFIGS. 29 a and 29 b with the exception that the needle assembly withneedle hub 321 is movably disposed in the coupler 323. The needle hub321 is movable between a first position where the needle canula 292 doesnot pierce the rubber closure 294 (also referred to as a stopper 294),or is only partly piercing the rubber closure 294, and a second positionwhere the needle tip pierces the stopper 294 to establish fluidcommunication with the fluid passageway 295.

FIG. 33 a to FIG. 33 c illustrates a pre-filled Luer syringe 259comprising a regular piston-and-barrel syringe arrangement with a stakedneedle 334 for delivering medication. A syringe cap 331 communicateswith the syringe in an aseptic engagement 337. The cap 331 is engagedwith a cartridge 10 to form a removable cartridge 330. The body of thecap 331 operates as a coupler between a fitment 336 of the cartridge andthe needle. FIGS. 33 d and 33 e show a scaled-up section view of the capduring storage and after activation as the dose 338 is being filled tothe syringe's barrel with a plunger 339. The cap comprises a rubberstopper 335 that is pierced through by the needle 334.

Similar configurations may be operative with other needle arrangementsknown in the art including, for example, syringe with catheter, needlewith protective soft sheath, intramuscular (IM) needle, Subcutaneous(SQ) needle, Intradermal (ID) needle, micro-needle, safety needles,retractable needle, irrigation needle, applicator, etc.

The syringe further comprises an aseptic closure 333 to the barrel suchthat this syringe assembly is maintained sterile without the need of asterile overwrap.

FIG. 34 illustrates an arrangement similar to the arrangement of FIG. 33with the addition of protective walls 341 vertically protruding toprotect the cartridge 10 of a removable cartridge 340. The protection ofthe cartridge can be enhanced by further surrounding the cartridge withadditional wall, a flip-over cover associated with the wall 341, aslidable cover, etc.

FIGS. 35 a to 35 f illustrate filling steps of one method of filling apackage 350. The package 350 comprises a first pre-formed wall 18′ and asecond flat wall 18″ joined to form a compartment 15. A fillingcompartment 201 is interfacing the storage compartment 15 via a sealablefilling channel 202. FIG. 35 a illustrates the package 350 prior tofilling, wherein a cavity defined by the storage compartment 15, thefilling compartment 201, and the filling channel 202 is integrallysealed. The package may be sterilized by heat or radiation.

FIG. 35 b illustrates the package 350 having a filling device 311 thatis engaged with the package 350. The filling device comprises a fillingtube 312 having a piercing member at its distal end for piercing thesecond wall 18″ of the package 350. The filling device 311 is engagedwith the second wall 18″ in a fluid tight fashion, and defines a fillingport where the filling tube 312 pierces the second wall 18″ in thefilling compartment 201. The filling tube 312 and the filling port maybe disinfected prior to engagement to further reduce contamination risksof the package. In one arrangement the package and the filling deviceare disinfected using hydrogen peroxide.

FIG. 35 c illustrates the filling device 311 starting to fill thepackage 350. The filling channel directs the fluid 313 to glide alongthe second wall 18″, hence reducing jetting, bubbles and foaming of thebeneficial agent 313. FIG. 35 d illustrates a subsequent step in thefilling process where the package is about half full. The fluidicconstituent 313 continues to flows along the second wall 18″ avoidingjetting and reducing bubbles, foaming and mixing of the filled product.A gas content within the package 350 may be evacuated through thefilling passageway 202 or another sealable filling outlet.

FIG. 35 e illustrates the storage compartment 15 completely filled andsealed. A sealing device collapses and thermally seals the channel 202.In one arrangement, the filling compartment 201 is squeezed prior tosealing the channel 202 to transfer the fluidic content of the fillingcompartment 201 to the storage compartment 15. In another arrangement,the fluidic content of the filling compartment 201 is sucked back intothe filling tube 312 after sealing the channel 202. FIG. 35 f shows thepackage after the filling device is retracted and the fillingcompartment 201 section is trimmed and sacrificed.

FIG. 36 illustrates an arrangement of a portion of a package 360 havinga first insert 361 disposed in the filling compartment 201, and a secondinsert 362 disposed in the filling channel 202. The first insert 361serves as a seal to enhance a fluid-tight seal between the fillingdevice 311 and the package 360. The second insert 362 comprises aninternal channel 363 configured to direct the incoming fluid tocompartment 15 to glide along the second wall 18″. In one arrangement,the second insert comprises a low-melting temperature material that isadherebly compatible with the first wall 18′ and the second wall 18″.Hence, the second insert 362 will melt, collapse, and seal the channel202 at the sealing step.

The cartridges of the arrangements of this disclosure may carry anymarking including printing, barcoding, RFID tags, embossment, andengraving to communicate desired information with a person or a device.The cartridge may be extended to provide sufficient marking surface asneeded.

A compression panel may be associated with the cartridge to facilitatedepression of at least one compartment of the cartridge either to urgethe rupture of a rupturable barrier, or to urge expression of thedispensable product from the cartridge.

The arrangement and method described above is applicable for otherinjectors or dispenser types such as the jet injector cartridge taughtin FIG. 1 or other arrangements discussed in this document. In onearrangement, a retractable needle mechanism, retractable needleconnector mechanism, or other needle safety mechanisms, and reusedisabling mechanism or prevention device is incorporated with the mixingsyringe mechanism described herein.

The cartridge arrangement of the present disclosure may be combined withseveral forms of delivery devices or applicators to facilitate a desiredform of use. A compression panel or roller may be incorporated tofacilitate an efficient expression of the cartridge's content. Thedelivery devices or applicators may include, for example, any one of amedical syringe, staked needle syringe, safety syringe, retractableneedle syringe, auto-disabling syringe, auto-injector, jet-injector,intradermal syringe, subcutaneous syringe, intramuscular syringe,infusor, infusion pump, sustained release delivery system, and patchpump.

The applications of the present invention are not limited to the syringeand jet-injector applications which are provided here by way of example,and the teachings described herein can be applied to other applicationssuch as aseptic filling of micro-pump reservoir, intramuscular autoinjectors, intradermal auto injectors, etc.

1.-255. (canceled)
 256. A cartridge for use with an injector,comprising: a first wall that comprises at least a first cavity; asecond wall in sealing engagement with the first wall to define at leasta first sealed compartment at least partially defined by the firstcavity, wherein the first sealed compartment is adapted to contain afirst deliverable substance; and a fitment to selectively provide fluidcommunication between the first sealed compartment and a reservoir ofthe injector via a passageway of the fitment to transfer the firstdeliverable substance from the first sealed compartment to the reservoirof the injector, wherein the fitment defines at least a portion of anaseptic zone through which the first deliverable substance istransferred between the cartridge and the reservoir.
 257. The cartridgeof claim 256, wherein the fitment is adapted to form a fluid-tight sealwith a nozzle of the injector.
 258. The cartridge of claim 257, whereinthe injector is a jet injector and the nozzle of the injector with whichthe fitment is adapted to engage includes a jet nozzle, and wherein thefitment engages the nozzle to define the aseptic zone through with thefirst deliverable substance is transferred between the cartridge and thereservoir.
 259. The cartridge of claim 256, wherein the fitment isattached to an outer side of one of the first wall and the second wall,the one of the first wall and the second wall including a through holeproviding the fluid communication between the first sealed compartmentand the passageway of the fitment.
 260. The cartridge of claim 256,wherein the fitment further comprises: a port area adapted to receive aportion of the injector; and an aseptic cover protecting the port areawhen the fitment is not engaged with the injector.
 261. The cartridge ofclaim 256, wherein the fitment further comprises: a port area havingconformal elements adapted to conform to structural elements of theinjector, wherein the conformal elements are adapted to maintain theaseptic zone when the cartridge is engaged with the injector.
 262. Thecartridge of claim 256, wherein the sealing engagement comprises: afirst frangible seal between the fitment and the first sealedcompartment, wherein the cartridge is adapted to provide the firstdeliverable substance by the first frangible seal being controllablypeelable responsive to depression of the first sealed compartment. 263.The cartridge of claim 262, wherein adherence of the first wall to thesecond wall in the first frangible seal is less than adherence of thefirst wall to the second wall in other portions of the sealingengagement.
 264. The cartridge of claim 262, further comprising: asecond sealed compartment containing a second deliverable substance,wherein the second deliverable substance is introduced to the secondsealed compartment prior to the sealing engagement of the first wall tothe second wall.
 265. The cartridge of claim 264, wherein the sealingengagement further comprises: a second frangible seal between the firstsealed compartment and the second sealed compartment, wherein depressingthe first sealed compartment causes peeling of the second frangibleseal, the peeling configured to establish fluid communication betweenthe first sealed compartment and the second sealed compartment.
 266. Thecartridge of claim 265, wherein the second deliverable substanceincludes one or more of a dry constituent, frozen liquid constituent,granulated constituent, micro-pellet constituent, sphere constituent,microsphere constituent, flowable powder constituent, compressed powderconstituent, cake constituent, lyophilized cake constituent or a solidconstituent of a beneficial agent and the first deliverable substanceincludes a fluid and wherein the peeling of the second frangible sealcauses mixing of the second deliverable substance with the firstdeliverable substance.
 267. The cartridge of claim 266, wherein thefluid includes a diluent operable to at least partially dissolve thesecond deliverable substance when the second frangible seal is peeled.268. The cartridge of claim 256, further comprising: a drying agent.269. The cartridge of claim 256, further comprising: a sterile overwrapfor storing the cartridge when the cartridge is not engaged with theinjector, wherein a drying agent is contained within the sterileoverwrap.
 270. The cartridge of claim 256, wherein one or more of thefirst or second wall include a drying agent.
 271. The cartridge of claim256, wherein one or more of the first wall or the second wall arecomposed of one or more of a film, a foil, an extruded web, a blown web,a cast web, a multilayer web, a laminated web, a coated web, a webincluding metallicized layers, a web including at least one metal-oxidelayer, a web including a high barrier layer, an aluminum containinglayer, alumina, silica, an Olefin Polymer, a Cyclic Olefin Copolymer, apolychlorotrifluoroethylene, or an Ethylene Vinyl Alcohol.
 272. Thecartridge of claim 256, the first wall further comprising at least oneoptical machine-readable indicium operable to provide informationregarding one or more of a content of the cartridge, operatinginstructions, or warnings.
 273. An injector system, comprising: aninjector including: a tubular body; a piston disposed in the tubularbody, wherein the piston provides a fluid-tight seal with the tubularbody defining a reservoir within portions of the tubular body notoccupied by the piston; a nozzle in fluid communication with thereservoir; and a cartridge including: a first wall that comprises atleast a first cavity; a second wall in sealing engagement with the firstwall to define at least a first sealed compartment at least partiallydefined by the first cavity, wherein the first sealed compartment isadapted to contain a first deliverable substance; and a fitmentengageable with the injector to selectively provide fluid communicationbetween the first sealed compartment and a nozzle of the injector via apassageway of the fitment to transfer the first deliverable substancefrom the first sealed compartment to a reservoir of the injector,wherein the fitment is engageable with the injector to define an asepticzone through which the first deliverable substance is transferredbetween the cartridge and the injector.
 274. The injector system ofclaim 273, wherein the injector is a jet injector and the nozzle of theinjector with which the fitment is adapted to engage includes a jetnozzle.
 275. The injector system of claim 273, wherein the fitment isadapted to form a fluid-tight seal with the nozzle of the injector. 276.The injector system of claim 273, further comprising: an aseptic covermaintaining sterility of one or more of the nozzle or the fitment whenthe cartridge is not engaged with the injector.
 277. The injector systemof claim 276, wherein the aseptic cover is one or more of a cap or asealed foil.
 278. The injector system of claim 273, wherein the tubularbody further comprises: structural elements adapted to conform toconformal elements of the fitment, wherein the structural elements areadapted to maintain the aseptic zone when the cartridge is engaged withthe injector.
 279. The injector system of claim 273, the piston movablewithin the tubular body, wherein the piston is movable to configurationsincluding an empty state when the piston is at a most proximal positionto the nozzle and a retracted state when the piston is moved distallyfrom the nozzle.
 280. The injector system of claim 279, wherein theretracted state is a filled state, the filled state resulting fromretracting of the piston from the tubular body when the injector isengaged with the cartridge, the retraction causing the first deliverablesubstance to flow into the reservoir.
 281. The injector system of claim273, wherein one or more of the tubular body or the piston are wrappedin a sterile overwrap.
 282. The injector system of claim 273, whereinthe injector system is assembled in a sterile environment, the injectoris engaged with the cartridge in the sterile environment, and theinjector system is provided in a non-sterile environment whilemaintaining the engagement between the injector and the cartridge in thenon-sterile environment.
 283. The injector system of claim 282, whereinthe engagement maintains the aseptic zone after the injector system isprovided in the non-sterile environment.